YAMADA Akira 山田亮

Researcher Number	50158177
External Links
Affiliation (Current)	2021: 久留米大学, 付置研究所, 教授
Affiliation (based on the past Project Information) *help	2012 – 2020: 久留米大学, 付置研究所, 教授 2016: 久留米大学, 医学部, 教授 2003 – 2016: 久留米大学, 先端癌治療研究センター, 教授 2011: 久留米大学, 先端癌治療センター, 教授 2006: 久留米大学, 医学部, 教授 … More
Review Section/Research Field	Principal Investigator Gastroenterology / Tumor immunology / Tumor therapeutics / Pathological medical chemistry / Respiratory organ internal medicine / Respiratory organ internal medicine / Basic Section 50020:Tumor diagnostics and therapeutics-related Except Principal Investigator Surgical dentistry / Urology / Clinical nursing … More
Keywords	Principal Investigator ペプチドワクチン / 癌 / 免疫療法 / 腫瘍免疫 / 接着分子 / 早期診断 / 遺伝子同定 / 腫瘍 / ウイルス / 感染症 … More Except Principal Investigator 癌 / キラーT細胞 / ペプチドワクチン / T細胞 / 免疫学 / バイオテクノロジー / 口腔癌 / 腫瘍免疫 / がんペプチドワクチン / 食道癌 / T細胞抗原レセプター遺伝子 / ヒト癌特異免疫 / ヒト癌退縮抗原遺伝子 / MAGE遺伝子ファミリー / cDNAクローニング / 癌抗原ペプチド / TCR usage / がん抗原 / T細胞抗原レセプター / がん退縮抗原遺伝子 / 扁平上皮癌 / HLA-クラスI拘束性 / 再燃前立腺癌 / テーラーメイド / 汎HLA / ペプチドワクチン療法 / HLA-A3ファミリー / 免疫療法 / ペプチド / 治療 / 診断 / 臨床 / オーダーメイド免疫療法 / 口腔扁平上皮癌 / RCAS1 / PD-L1 / 腫瘍会合性マクロファージ / 免疫チェックポイント分子 / 腫瘍随伴性マクロファージ / 癌ペプチド / オーダーメイドワクチン / アポトーシス / 先進医療 / 患者支援システムの構築 / SOC / QOL / がん患者への援助 / がん患者のQOLとSOC / 癌特異免疫 / 癌退縮抗原 / 遺伝子クローニング / 抗原ペプチド / 転移性リンパ節 / 癌ワクチン / Esophageal cancer. / Cancer-specific immunity. / Cytotoxic Tlymphocytes. / Tumor-rejection antigens. / Gene cloning. / Antigenic peptides. / Metastatic lymph nodes. / Cancer vaccine. / アレルギー・ぜんそく / ウィルス / cancer / virus / allergy / biotechnology / immunology / T細胞サブセット / 包括的TCR解析 / 食道扁平上皮癌 / TCR解析 / TIL / サブセット / T cell subset / 炎症とがん / 経皮ワクチン / トリプルネガティブ乳癌 / 乳がん / トリプルネガティブ乳がん / 腫瘍由来ミトコンドリアDAMPｓ / 抗腫瘍免疫 / ホルミルペプチド / がん免疫療法 Less

腫瘍由来ミトコンドリアDAMPsの抗腫瘍免疫における機能解析と癌免疫療法への応用
- Principal Investigator
  
  和氣加容子
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Kurume University
Role of HMGB1 on anti-tumor immunity and its application for cancer immunotherapyPrincipal Investigator
- Principal Investigator
  
  山田亮
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Kurume University
A basic research to develop cancer peptide vaccine for transdermal immunization
- Principal Investigator
  
  Waki Kayoko
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Kurume University
TCR repertoire analysis in esophageal cancer
- Principal Investigator
  
  Sudo Tomoya
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Tumor biology
- Research Institution
  Kurume University
Development of next generation transdermal vaccine for cancer treatmentPrincipal Investigator
- Principal Investigator
  
  YAMADA Akira
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Kurume University
The Development of Peptide Vaccines for Triple Negative Breast Cancer Treatment
- Principal Investigator
  
  Toh Uhi
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General surgery
- Research Institution
  Kurume University
Construction of support system for the cancer patients who have advanced medicine
- Principal Investigator
  
  Mayumi TAMURA
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Clinical nursing
- Research Institution
  St. Mary's College
  University of Miyazaki
Development of early diagnostic method and order-made immunotherapy for oral cancer by using anti-tumor T cells
- Principal Investigator
  
  Nakamura Seiji
- Project Period (FY)
  2012 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (A)
- Research Field
  
  Surgical dentistry
- Research Institution
  Kyushu University
Basic research for the development of multi-peptide cocktail vaccines for cancerPrincipal Investigator
- Principal Investigator
  
  YAMADA Akira
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Tumor immunology
- Research Institution
  Kurume University
Development of early-diagnosis and made-to-order immunotherapy fororal cancers by using cancer-specific peptides
- Principal Investigator
  
  NAKAMURA Seiji
- Project Period (FY)
  2008 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Surgical dentistry
- Research Institution
  Kyushu University
Fundamental study for development of a peptide vaccine against hepatitis C virusPrincipal Investigator
- Principal Investigator
  
  YAMADA Akira
- Project Period (FY)
  2008 – 2010
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Kurume University
Basic and clinical research on pan-HLA peptide vaccination for prostate cancer
- Principal Investigator
  
  NOGUCHI Masanori
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Kurume University
Study of molecular basis for T cell-mediated recognition of antigens in subjects with HLA-A3 super type
- Principal Investigator
  
  ITOH Kyogo
- Project Period (FY)
  2006 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Living organism molecular science
- Research Institution
  Kurume University
Basic research for the development of peptide vaccination against Hepatitis C virus infectionPrincipal Investigator
- Principal Investigator
  
  YAMADA Akira
- Project Period (FY)
  2006 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Kurume University
Identification of new lung cancer antigens and development of peptide vaccinePrincipal Investigator
- Principal Investigator
  
  YAMADA Akira
- Project Period (FY)
  2003 – 2005
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Kurume University
Identification of Genes Encoding Lung Cancer Antigens Recognized by Cytotoxic T-lymphocytes and Development of Cancer VaccinesPrincipal Investigator
- Principal Investigator
  
  YAMADA Akira
- Project Period (FY)
  2000 – 2002
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  KURUME UNIVERSITY
HLA-A2拘束性卵巣癌特異的癌退縮抗原遺伝子のクローニングPrincipal Investigator
- Principal Investigator
  
  山田亮
- Project Period (FY)
  1996
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Research Institution
  Kurume University
Establishment of tumor specific killer T-cells and the cloning of the tumor rejection antigen gene
- Principal Investigator
  
  YAMANA Hideaki
- Project Period (FY)
  1996 – 1997
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  Kurume University School of Medicine
接着分子を用いた癌の早期診断:癌患者外分泌腺上LFA-1(様)抗原の遺伝子同定Principal Investigator
- Principal Investigator
  
  山田亮
- Project Period (FY)
  1994
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Research Institution
  Kurume University
ヒトがん特異的T細胞抗原レセプター遺伝子の解析
- Principal Investigator
  
  伊東恭悟
- Project Period (FY)
  1994
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Research Institution
  Kurume University
Molecular Characterizaiton of LFA-1-like Molecule on Exocrine Glands in Patients with Malignant Tumor.Principal Investigator
- Principal Investigator
  
  YAMADA Akira
- Project Period (FY)
  1994 – 1995
- Research Category
  
  Grant-in-Aid for General Scientific Research (C)
- Research Field
  
  Pathological medical chemistry
- Research Institution
  Kurume University School of Medicine
ヒトがん特異的T細胞抗原レセプター遺伝子の解析
- Principal Investigator
  
  ITOH Kyogo
- Project Period (FY)
  1993
- Research Category
  
  Grant-in-Aid for Cancer Research
- Research Institution
  Kurume University

[Journal Article] Immunological evaluation of peptide vaccination for cancer patients with the HLA-A11+ or -A33+ allele.2017
- Author(s)
  Sakamoto S, Matsueda S, Takamori S, Toh U, Noguchi M, Yutani S, Yamada A, Shichijo S, Yamada T, Suekane S, Kawano K, Naitou M, Sasada T, Hattori N, Kohno N, Itoh K.
- Journal Title
  
  Cancer Science
  
  Volume: 印刷中 Pages: 598-603
- DOI
  10.1111/cas.13189
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176, KAKENHI-PROJECT-16K15601, KAKENHI-PROJECT-17K07229, KAKENHI-PROJECT-15H04831
[Journal Article] Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung Cancer2017
- Author(s)
  Sakamoto S, Yamada T, Terazaki Y, Yoshiyama K, Sugawara S, Takamori S, Matsueda S, Shichijo S, Yamada A, Noguchi M, Itoh K, Hattori N, Kohno N, Sasada T.
- Journal Title
  
  Clinical Lung Cancer
  
  Volume: 印刷中
- DOI
  10.1016/j.cllc.2017.03.011
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176, KAKENHI-PROJECT-16K15601, KAKENHI-PROJECT-17K07229, KAKENHI-PROJECT-15H04831
[Journal Article] Clinical Impact of Tumor-Infiltrating Lymphocytes in Esophageal Squamous Cell Carcinoma2017
- Author(s)
  Sudo T, Nishida R, Kawahara A, Saisho K, Mimori K, Yamada A, Mizoguchi A, Kadoya K, Matono S, Mori N, Tanaka T, Akagi Y.
- Journal Title
  
  Annals of Surgical Oncology
  
  Volume: in press Pages: 3763-3770
- DOI
  10.1245/s10434-017-5796-4
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26430176, KAKENHI-PROJECT-16K07130, KAKENHI-PROJECT-17K19608, KAKENHI-PUBLICLY-16H01576, KAKENHI-PROJECT-15H04921
[Journal Article] A randomized phase II trial of personalized peptide vaccine with low dose cyclophosphamide in biliary tract cancer2017
- Author(s)
  Shirahama T, Muroya D, Matsueda S, Yamada A, Shichijo S, Naito M, Yamashita T, Sakamoto S, Okuda K, Itoh K, Sasada T, Yutani S.
- Journal Title
  
  Cancer Science
  
  Volume: 印刷中 Pages: 838-845
- DOI
  10.1111/cas.13193
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176, KAKENHI-PROJECT-16K15601, KAKENHI-PROJECT-17K07229
[Journal Article] Immunological efficacy of herbal medicines in prostate cancer patients treated by personalized peptide vaccine2017
- Author(s)
  Koga Noriko、Moriya Fukuko、Waki Kayoko、Yamada Akira、Itoh Kyogo、Noguchi Masanori
- Journal Title
  
  Cancer Science
  
  Volume: 108 Pages: 2326-2332
- DOI
  10.1111/cas.13397
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K07229
[Journal Article] Plasma Levels of High-Mobility Group Box 1 during Peptide Vaccination in Patients with Recurrent Ovarian Cancer2017
- Author(s)
  Waki K, Kawano K, Tsuda N, Ushijima K, Itoh K, Yamada A.
- Journal Title
  
  Journal of Immunology Research
  
  Volume: 2017 Pages: 1423683-1423683
- DOI
  10.1155/2017/1423683
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26430176, KAKENHI-PROJECT-17K07229
[Journal Article] Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies.2017
- Author(s)
  Yutani Shigeru、Shirahama Takahisa、Muroya Daisuke、Matsueda Satoko、Yamaguchi Rin、Morita Michi、Shichijo Shigeki、Yamada Akira、Sasada Tetsuro、Itoh Kyogo
- Journal Title
  
  Cancer Sci.
  
  Volume: 108 Pages: 1732-1738
- DOI
  10.1111/cas.13301
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K07229, KAKENHI-PROJECT-16K15601
[Journal Article] トリプルネガティブ乳がんに対する混合ペプチドワクチン（KRM-19）療法の臨床的検討2016
- Author(s)
  唐宇飛、朔周子、岡部実奈、岩熊伸高、君付優子、赤司桃子、淡河恵津世、山田亮、七條茂樹、伊東恭悟、赤木由人
- Journal Title
  
  癌と化学療法
  
  Volume: 第43巻第10号 Pages: 1249-1251
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26430176
[Journal Article] Single nucleotide polymorphisms of the Haptoglobin gene in non-small cell lung cancer treated with personalized peptide vaccination.2016
- Author(s)
  Waki K, Yamada T, Yoshiyama K, Terazaki Y, Sakamoto S, Sugawara S, Takamori S, Itoh K, Yamada A.
- Journal Title
  
  Oncol Letter 2016
  
  Volume: in press
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26430176
[Journal Article] A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer.2016
- Author(s)
  Noguchi M, Moriya F, Koga N, Matsueda S, Sasada T, Yamada A, Kakuma T, Itoh K.
- Journal Title
  
  Cancer Immunol Immunother
  
  Volume: 65 Pages: 151-60
- DOI
  10.1007/s00262-015-1781-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Blockade of High Mobility Group Box 1 (HMGB1) augments anti-tumor T-cell response induced by peptide vaccination as a co-adjuvant.2016
- Author(s)
  Waki K, Yamada A.
- Journal Title
  
  Cancer Sci.
  
  Volume: 107(12) Pages: 1721-1729
- DOI
  10.1111/cas.13084
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26430176
[Journal Article] トリプルネガティブ乳がんに対する混合ペプチドワクチン（KRM-19）療法の臨床的検討2016
- Author(s)
  唐　宇飛、朔　周子、岡部実奈、岩熊伸高、君付優子、赤司桃子、淡河恵津世、山田　亮、七條茂樹、伊東恭悟、赤木由人
- Journal Title
  
  癌と化学療法
  
  Volume: 43（10） Pages: 1249-1251
- Data Source
  KAKENHI-PROJECT-26461965
[Journal Article] Immunological evaluation of personalized peptide vaccination for patients with histologically unfavorable carcinoma of unknown primary site.2016
- Author(s)
  Sakamoto S, Yutani S, Shichijo S, Morita M, Yamada A, Itoh K, Noguchi M.
- Journal Title
  
  Cancer Immunol Immunother.
  
  Volume: 65(10) Pages: 1223-1231
- DOI
  10.1007/s00262-016-1887-5
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26430176
[Journal Article] Identification and gene of new major allergen Cha o 3 from Chamaecyparis obtusa (Japanes Cypress) pollen.2016
- Author(s)
  Osada T, Harada T, Asaka N, Kino K, Sasaki E, Okano M, Yamada A, Utsugi T.
- Journal Title
  
  J allergy clin immunol.
  
  Volume: In press
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26430176
[Journal Article] Personalized Kampo Medicine Facilitated Both Cytotoxic T Lymphocyte Response and Clinical Benefits Induced by Personalized Peptide Vaccination for Advanced Esophageal Cancer.2016
- Author(s)
  Muroya D, Yutani S, Shichijo S, Yamada A, Sakamoto S, Naito M, Okuda K, Morita M, Yamaguchi R, Itoh K.
- Journal Title
  
  Evid Based Complement Alternat Med.
  
  Volume: 2016 Pages: 5929525-5929525
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26430176
[Journal Article] Randomized phase II study of docetaxel plus personalized peptide vaccination versus docetaxel plus placebo for patients with previously treated advanced wild type EGFR non-small-cell lung cancer.2016
- Author(s)
  Takayama K, Sugawara S, Saijo Y, Maemondo M, Sato A, Takamori S, Harada T, Sasada T, Kakuma T, Kishimoto J, Yamada A, Noguchi M, Itoh K, Nakanishi Y.
- Journal Title
  
  Immunol Res.
  
  Volume: In press
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26430176
[Journal Article] 急速に発展する免疫療法：がんワクチンの新展開2016
- Author(s)
  和氣加容子、山田亮
- Journal Title
  
  BIO INDUSTRY
  
  Volume: 第33巻第5号 Pages: 11-18
- Data Source
  KAKENHI-PROJECT-26430176
[Journal Article] Phase I study of a new cancer vaccine of ten mixed peptides for advanced cancer patients.2016
- Author(s)
  Iwasa S, Yamada Y, Heike Y, Shoji H, Honma Y, Komatsu N, Matsueda S, Yamada A, Morita M, Yamaguchi R, Tanaka N, Kawahara A, Kage M, Shichijo S, Sasada T, Itoh K.
- Journal Title
  
  Cancer Sci.
  
  Volume: 印刷中 Pages: 590-600
- DOI
  10.1111/cas.12919
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176, KAKENHI-PROJECT-16K19381
[Journal Article] A Phase 2 Randomized Controlled Trial of Personalized Peptide Vaccine Immunotherapy with Low-dose Dexamethasone Versus Dexamethasone Alone in Chemotherapy-naive Castration-resistant Prostate Cancer.2016
- Author(s)
  Yoshimura K, Minami T, Nozawa M, Kimura T, Egawa S, Fujimoto H, Yamada A, Itoh K, Uemura H.
- Journal Title
  
  Eur Urol
  
  Volume: 70(1) Pages: 35-41
- DOI
  10.1016/j.eururo.2015.12.050
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26430176
[Journal Article] Phase II study of personalized peptide vaccination with both a hepatitis C virus (HCV)-derived peptide and peptides from tumor-associated antigens for the treatment of HCV-positive advanced hepatocellular carcinoma patients.2015
- Author(s)
  Yutani S, Ueshima K, Abe K, Ishiguro A, Eguchi J, Matsueda S, Komatsu N, Shichijo S, Yamada A, Itoh K, Sasada T, Kudo M, Noguchi M.
- Journal Title
  
  J Immunol Res.
  
  Volume: 2015 Pages: 473909-473909
- DOI
  10.1155/2015/473909
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Evaluation of prognostic significance of granulocyte-related factors in cancer patients undergoing personalized peptide vaccination.2015
- Author(s)
  Sakamoto S, Yoshitomi M, Yutani S, Terazaki Y, Yoshiyama K, Ioji T, Matsueda S, Yamada A, Takamori S, Itoh K, Hattori N, Kohno N, Sasada T.
- Journal Title
  
  Human Vaccine Immunother.
  
  Volume: 11 Pages: 2784-9
- DOI
  10.1080/21645515.2015.1075107
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens.2015
- Author(s)
  Yamada T, Terazaki Y, Sakamoto S, Yoshiyama K, Matsueda S, Komatsu N, Waki K, Yamada A, Kawahara A, Kage M, Sugawara S, Yamashita Y, Sasada T, Takamori S, Itoh K.
- Journal Title
  
  Int J Oncol.
  
  Volume: 46 Pages: 55-62
- DOI
  10.3892/ijo.2014.2699
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 allele.2015
- Author(s)
  Sakamoto S, Matsueda S, Takamori S, Toh U, Noguchi M, Yutani S, Yamada A, Shichijo S, Yamada T, Suekane S, Kawano K, Sasada T, Hattori N, Kohno N, Itoh K.
- Journal Title
  
  Cancer Sci
  
  Volume: 106 Pages: 1257-1263
- DOI
  10.1111/cas.12757
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26461965, KAKENHI-PROJECT-15H04831, KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression.2015
- Author(s)
  Noguchi M, Arai G, Matsumoto K, Naito S, Moriya F, Suekane S, Komatsu N, Matsueda S, Sasada T, Yamada A, Itoh K.
- Journal Title
  
  Cancer Immunol Immunother
  
  Volume: 64 Pages: 493-505
- DOI
  10.1007/s00262-015-1660-1
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24592408, KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Personalized peptide vaccination for cervical cancer patients who have received prior platinum-based chemotherapy.2015
- Author(s)
  Kawano K, Tsuda N, Waki K, Matsueda S, Hata Y, Ushijima K, Itoh K, Yamada A, Kamura T.
- Journal Title
  
  Cancer Sci.
  
  Volume: 106(9) Pages: 1111-7
- DOI
  10.1111/cas.12729
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26430176
[Journal Article] Identification of novel Lck-derived T helper epitope long peptides applicable for HLA-A2(+) cancer patients as cancer vaccine.2015
- Author(s)
  Matsueda S, Shichijo S, Nagata S, Seki C, Yamada A, Noguchi M, Itoh K.
- Journal Title
  
  Cancer Sci.
  
  Volume: 106(11) Pages: 1493-8
- DOI
  10.1111/cas.12805
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26430176
[Journal Article] Personalized Peptide Vaccine for Treatment of Advanced Cancer2014
- Author(s)
  Sasada T, Yamada A, Noguchi M, Itoh K
- Journal Title
  
  Curr Med Chem
  
  Volume: (Epub ahead of print)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292
[Journal Article] The influence of Chlorella and its hot water extract supplementation on quality of life in patients with breast cancer.2014
- Author(s)
  Noguchi N, Maruyama I, Yamada A.
- Journal Title
  
  Evidence-Based Complementary and Alternative Medicine
  
  Volume: in press
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292
[Journal Article] The influence of Chlorella and its hot water extract supplementation on quality of life in patients with breast cancer.2014
- Author(s)
  Noguchi N, Maruyama I, Yamada A.
- Journal Title
  
  Evid Based Complement Alternat Med
  
  Volume: 2014:704619
- DOI
  10.1155/2014/704619
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26430176
[Journal Article] Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients.2014
- Author(s)
  Takahashi R, Toh U, Iwakuma N, Takenaka M, Otsuka H, Furukawa M, Fujii T, Seki N, Kawahara A, Kage M, Matsueda S, Akagi Y, Yamada A, Itoh K, Sasada T.
- Journal Title
  
  Breast Cancer Res
  
  Volume: 16 Pages: 00-00
- DOI
  10.1186/bcr3685
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23591914, KAKENHI-PROJECT-24591925, KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176, KAKENHI-PROJECT-26461965
[Journal Article] Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer.2014
- Author(s)
  Kibe S, Yutani S, Motoyama S, Nomura T, Tanaka N, Kawahara A, Yamaguchi T, Matsueda S, Komatsu N, Miura M, Hinai Y, Hattori S, Yamada A, Kage M, Itoh K, Akagi Y, Sasada T.
- Journal Title
  
  Cancer Immunol Res.
  
  Volume: 2 Pages: 1154-1162
- DOI
  10.1158/2326-6066.cir-14-0035
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Feasibility study of personalized peptide vaccination for recurrent ovarian cancer patients.2014
- Author(s)
  Kawano K, Tsuda N, Matsueda S, Sasada T, Watanabe N, Ushijima K, Yamaguchi T, Yokomine M, Itoh K, Yamada A, Kamura T.
- Journal Title
  
  Immunopharmacol Immunotoxicol
  
  Volume: 36 Pages: 224-236
- DOI
  10.3109/08923973.2014.913617
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23591913, KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Personalized Peptide Vaccine for Treatment of Advanced Cancer.2014
- Author(s)
  Sasada T, Yamada A, Noguchi M, Itoh K.
- Journal Title
  
  Curr Med Chem
  
  Volume: Epub ahead of print
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292
[Journal Article] Feasibility study of personalized peptide vaccination for recurrent ovarian cancer patients.2014
- Author(s)
  Kawano K, Tsuda N, Matsueda S, Sasada T, Watanabe N, Ushijima K, Yamaguchi T, Yokomine M, Itoh K, Yamada A, Kamura T.
- Journal Title
  
  Immunopharmacol Immunotoxicol
  
  Volume: in press
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292
[Journal Article] The influence of Chlorella and its hot water extract supplementation on quality of life in patients with breast cancer2014
- Author(s)
  Noguchi N, Maruyama I, Yamada A
- Journal Title
  
  Evidence-Based Complementary and Alternative Medicine
  
  Volume: (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292
[Journal Article] PD-1 expression on peripheral blood T-cell subsets correlates with prognosis in non-small cell lung cancer.2014
- Author(s)
  Waki K, Yamada T, Yoshiyama K, Terazaki Y, Sakamoto S, Matsueda S, Komatsu N, Sugawara S, Takamori S, Itoh K, Yamada A.
- Journal Title
  
  Cancer Science
  
  Volume: 105(10) Pages: 1229-35
- DOI
  10.1111/cas.12502
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26430176
[Journal Article] Humoral immune responses to CTL epitope peptides from tumor-associated antigens are widely detectable in humans: a new biomarker for overall survival of patients with malignant diseases2013
- Author(s)
  Matsueda S, Komatsu N, Kusumoto K, Koga S, Yamada A, Kuromatsu R, Yamada S, Seki R, Yutani S, Shichijo S, Mine T, Fukuda T, Okamura T, Okuda S, Sata M, Honda J, Kaji M, Itoh K, Sasada T.
- Journal Title
  
  Dev Comp Immunol
  
  Volume: 41(1) Pages: 68-76
- DOI
  10.1016/j.dci.2013.04.004
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913, KAKENHI-PROJECT-24791452
[Journal Article] A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patients.2013
- Author(s)
  Yutani S., Komatsu N., Yoshitomi M., 他8名
- Journal Title
  
  Oncol Rep
  
  Volume: 30 Pages: 1094-100
- DOI
  10.3892/or.2013.2556
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22700297, KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913
[Journal Article] The next generation of peptide vaccines for advanced cancer2013
- Author(s)
  Yamada A, Sasada T, Noguchi M, Itoh K.
- Journal Title
  
  Cancer Sci.
  
  Volume: 104(1) Pages: 15-21
- DOI
  10.1111/cas.12050
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913
[Journal Article] がんペプチドワクチンの開発　～アカデミアからの挑戦2013
- Author(s)
  山田亮、伊東恭悟
- Journal Title
  
  実験医学
  
  Volume: Vol.31 No.1 Pages: 105-110
- Data Source
  KAKENHI-PROJECT-23501292
[Journal Article] Controversies in Clinical Trials of Cancer Vaccines for Glioblastoma,2013
- Author(s)
  Terasaki1 M, Murotani K, Narita Y, Nishikawa R, Sasada T, Yamada A, Itoh K, Morioka M.
- Journal Title
  
  J Vaccines Vaccin.
  
  Volume: 4 Pages: 171-171
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292
[Journal Article] Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine2013
- Author(s)
  Yutani S, Komatsu N, Matsueda S, Yoshitomi M, Shirahama T, Yamada A, Itoh K, Sasada T.
- Journal Title
  
  Evid-Based Compl Alt.
  
  Volume: 2013 Pages: 1-10
- DOI
  10.1155/2013/981717
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913, KAKENHI-PROJECT-24791452
[Journal Article] Current status of immunotherapy for the treatment of biliary tract cancer2013
- Author(s)
  Takahashi R, Yoshitomi M, Yutani S, Shirahama T, Noguchi M, Yamada A, Itoh K, Sasada T.
- Journal Title
  
  Hum Vaccin Immunother
  
  Volume: 9(5) Pages: 1069-1072
- DOI
  10.4161/hv.23844
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292
[Journal Article] Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination.2012
- Author(s)
  Komatsu N, Noguchi M, et al
- Journal Title
  
  Cancer
  
  Volume: (In press) Pages: 3208-3221
- DOI
  10.1002/cncr.26636
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591782, KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913
[Journal Article] In vitro induction of specific CD8+ T lymphocytes by tumor-associated antigenic peptides in patients with oral squamous cell carcinoma2012
- Author(s)
  Toyoshima T, Kumamaru W, Hayashida J-N, Moriyama M, Kitamura R, Tanaka H, Yamada A, Itoh K, Nakamura S
- Journal Title
  
  Cancer Letter
  
  Volume: (In press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20390518
[Journal Article] In vitro induction of specific CD8+ T lymphocytes by tumor-associated antigenic peptides in patients with oral squamous cell carcinoma.2012
- Author(s)
  Toyoshima, T., Kumamaru, W., Hayashida, J.-N., Moriyama, M., Kitamura, R., Tanaka, H., Yamada, A., Itoh, K., and Nakamura, S.
- Journal Title
  
  Cancer Lett.
  
  Volume: 322 Pages: 86-91
- DOI
  10.1016/j.canlet.2012.02.016
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20390518, KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-24249091
[Journal Article] Personalized peptide vaccination in patients with refractory non-small cell lung cancer2012
- Author(s)
  Yoshiyama K, Terazaki Y, Satoko Matsueda S, Shichijo S, Noguchi M, Yamada A, Mine T, Ioji T, Itoh K, Shirouzu K, Sasada T and Takamori S.
- Journal Title
  
  Int J Oncol.
  
  Volume: 40 Pages: 1492-1500
- DOI
  10.3892/ijo.2012.1351
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913
[Journal Article] In vitro induction of specific CD8+ T lymphocytes by tumor-associated antigenic peptides in patients with oral squamous cell carcinoma.2012
- Author(s)
  Toyoshima T, Kumamaru W, Hayashida J, Moriyama M, Kitamura R, Tanaka H, Yamada A, Itoh K, Nakamura S.
- Journal Title
  
  Cancer Letter
  
  Volume: in press
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292
[Journal Article] テーラーメイドがんペプチドワクチン療法2012
- Author(s)
  山田亮
- Journal Title
  
  G.I.Research
  
  Volume: vol.20 no.2 Pages: 10-15
- Data Source
  KAKENHI-PROJECT-23501292
[Journal Article] Personalized peptide vaccination for advanced biliary tract cancer: IL-6, nutritional status, and pre-existing antigen-specific immunity as possible biomarkers for patient prognosis.2012
- Author(s)
  Yoshitomi M, Yutani S, Matsueda S, Ioji T, Komatsu N, Shichijo S, Yamada A, Itoh K, Sasada T, Kinoshita H.
- Journal Title
  
  Exp Ther Med
  
  Volume: 3 Pages: 463-469
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292
[Journal Article] Personalized peptide vaccination: a novel immunotherapeutic approach for advanced cancer.2012
- Author(s)
  Sasada T, Noguchi M, et al.
- Journal Title
  
  Hum Vaccin Immunother.
  
  Volume: 8 Pages: 1309-13
- DOI
  10.4161/hv.20988
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591782, KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913
[Journal Article] Personalized peptide vaccination for advanced biliary tract cancer: IL-6, nutritional status, and pre-existing antigen -specific immunity as possible biomarkers for patient prognosis.2012
- Author(s)
  Yoshitomi M, Yutani S, Matsueda S, Ioji T, Komatsu N, Shichijo S, Yamada A, Itoh K, Sasada T, Kinoshita H.
- Journal Title
  
  Exp Ther Med
  
  Volume: 3 Pages: 463-469
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292
[Journal Article] Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy.2012
- Author(s)
  Noguchi M, et al
- Journal Title
  
  Prostate
  
  Volume: 71 Pages: 470-479
- DOI
  10.1002/pros.21485
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591782, KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913
[Journal Article] Personalized peptide vaccination in patients with refractory non-small cell lung cancer.2012
- Author(s)
  Yoshiyama K, Terazaki Y, Matsueda S, Shichijo S, Noguchi M, Yamada A, Takashi M, Tetsuya I, Kyogo I, Kazuo S, Tetsuro S, Shinzo T.
- Journal Title
  
  Int J Oncol
  
  Volume: 40 Pages: 1492-1500
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292
[Journal Article] Immunological Evaluation of Personalized Peptide Vaccination in Refractory Small Cell Lung Cancer2012
- Author(s)
  Terazaki Y, Yoshiyama K, Matsueda S, Watanabe N, Yamada A, Mine T, Terasaki M, Itoh K, Takamori S, Sasada T.
- Journal Title
  
  Cancer Sci.
  
  Volume: 103(4) Pages: 638-44
- DOI
  10.1111/j.1349-7006.2012.02202.x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913, KAKENHI-PROJECT-23790425
[Journal Article] Characteristics of severe adverse events after peptide vaccination for advanced cancer patients : analysis of 500 cases.2011
- Author(s)
  Yoshida K, Noguchi M, Mine T, Komatsu N, Yutani S, Ueno T, Yanagimoto H, Kawano K, Itoh K, Yamada A.
- Journal Title
  
  Oncol Report
  
  Volume: 25(1) Pages: 57-62
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] A phase I study of personalized peptide vaccination using 14 kinds of vaccine in combination with low-dose estramustine in HLA-A24-positive patients with castration-resistant prostate cancer.2011
- Author(s)
  Noguchi M, Uemura H, Naito N, Akaza H, Yamada A, Itoh K.
- Journal Title
  
  Prostate 71(5)
  
  Pages: 470-9
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] Phase-I clinical study of a personalized peptide vaccination available for six different HLA (HLA-A2, -A3, -A11, -A24, -A31, and -A33)-positive patients with advanced cancer.2011
- Author(s)
  Yamada A, Noguchi M, Komatsu N, Suekane S, Yutani S, Moriya F, Mine T, Momozono K, Kawano K, Itoh K.
- Journal Title
  
  Exp Ther Med. 2
  
  Pages: 109-117
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] A phase I study of personalized peptide vaccination using 14 kinds of vaccine in combination with low-dose estramustine in HLA-A24-positive patients with castration-resistant prostate cancer2011
- Author(s)
  Noguchi M, Uemura H, Naito S, Akaza H, Yamada A, Itoh K
- Journal Title
  
  Prostate
  
  Volume: 71(5) Pages: 470-479
- DOI
  10.1002/pros.21261
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292
[Journal Article] Phase-I clinical study of a personalized peptide vaccination available for six different HLA (HLA-A2, -A3, -All, -A24, -A31, and-A33)-positive patients with advanced cancer.2011
- Author(s)
  Yamada A, Noguchi M, Komatsu N, Suekane S, Yutani S, Moriya F, Mine T, Momozono K, Kawano K, Itoh K.
- Journal Title
  
  Exp Ther Med.
  
  Volume: 2 Pages: 109-117
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] Phase-I clinical study of a personalized peptide vaccination available for six different HLA (HLA-A2, -A3, -A11, -A24, -A31, and -A33)-positive patients with advanced cancer.2011
- Author(s)
  Yamada A, Noguchi M, Komatsu N, Suekane S, Yutani S, Moriya F, Mine T, Momozono K, Kawano K, Itoh K.
- Journal Title
  
  Exp Ther Med
  
  Volume: 2 Pages: 109-117
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292
[Journal Article] A Phase I Trial of Personalized Peptide Vaccine for HLA-A24 Patients with Recurrent or Progressive Glioblastoma Multiforme.2011
- Author(s)
  Terasaki M,Shibui S, Narita Y, Fujimaki T, Aoki T, Kajiwara K, Sawamura Y, Kurisu K, Mineta T, Yamada A, Itoh K.
- Journal Title
  
  J Clin Oncol
  
  Volume: 29 Pages: 337-344
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292
[Journal Article] Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination.2011
- Author(s)
  Noguchi M, Mine T, Komatsu N, Suekane S, Moriya F, Matsuoka K, Yutani S, Shichijo S, Yamada A, Toh U, Kawano K, Azuma K, Uemura H, Okuno K, Matsumoto K, Yanagimoto H, Yamanaka R, Oka M, Todo S, Sasada T, Itoh K.
- Journal Title
  
  Cancer Biol Ther. 12;10(12)
  
  Pages: 1266-79
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] Phase I trial of a personalized Peptide vaccine for patients positive for human leukocyte antigen--A24 with recurrent or progressive glioblastoma multiforme.2011
- Author(s)
  Terasaki M, Shibui S, Narita Y, Fujimaki T, Aoki T, Kajiwara K, Sawamura Y, Kurisu K, Mineta T, Yamada A, Itoh K.
- Journal Title
  
  J Clin Oncol. 20;29(3)
  
  Pages: 337-44
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination.2011
- Author(s)
  Noguchi M, Mine T, Yamada A, et al.
- Journal Title
  
  Cancer Biol Ther
  
  Volume: 10 Pages: 1266-1279
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292
[Journal Article] A phase I study of personalized peptide vaccination using 14 kinds of vaccine in combination with low-dose estramustine in HLA-A24-positive patients with castration-resistant prostate cancer.2011
- Author(s)
  Noguchi M, Uemura H, Naito N, Akaza H, Yamada A, Itoh K.
- Journal Title
  
  Prostate.
  
  Volume: 71(5) Pages: 470-479
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] A phase I study of personalized peptide vaccination using 14 kinds of vaccine in combination with low-dose estramustine in HLA-A24-positive patients with castration-resistant prostate cancer.2011
- Author(s)
  Noguchi M, Uemura H, Naito S, Akaza H, Yamada A, Itoh K.
- Journal Title
  
  Prostate
  
  Volume: 71 Pages: 470-479
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292
[Journal Article] Characteristics of severe adverse events after peptide vaccination for advanced cancer patients : analysis of 500 cases.2011
- Author(s)
  Yoshida K, Noguchi M, Mine T, Komatsu N, Yutani S, Ueno T, Yanagimoto H, Kawano K, Itoh K, Yamada A.
- Journal Title
  
  Oncol Report 25(1)
  
  Pages: 57-62
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] A phase I study of personalized peptide vaccination for advanced urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and cisplatin.2011
- Author(s)
  Matsumoto K, Noguchi M, Satoh T, Tabata K, Fujita T, Iwamura M, Yamada A, Komatsu N, Baba S, Itoh K.
- Journal Title
  
  BJU Int
  
  Volume: 108 Pages: 831-838
- DOI
  10.1111/j.1464-410x.2010.09933.x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292
[Journal Article] Phase I trial of a personalized Peptide vaccine for patients positive for human leukocyte antigen--A24 with recurrent or progressive glioblastoma multiforme.2011
- Author(s)
  Terasaki M, Shibui S, Narita Y, Fujimaki T, Aoki T, Kajiwara K, Sawamura Y, Kurisu K, Mineta T, Yamada A, Itoh K
- Journal Title
  
  J Clin Oncol.
  
  Volume: 29(3) Pages: 337-344
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] Characteristics of severe adverse events after peptide vaccination for advanced cancer patients: analysis of 500 cases.2011
- Author(s)
  Yoshida K, Noguchi M, Mine T, Komatsu N, Yutani S, Ueno T, Yanagimoto H, Kawano K, Itoh K, Yamada A.
- Journal Title
  
  Oncol Report
  
  Volume: 25 Pages: 57-62
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292
[Journal Article] Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination.2011
- Author(s)
  Noguchi M, Mine T, Komatsu N, Suekane S, Moriya F, Matsuoka K, Yutani S, Shichijo S, Yamada A, Toh U, Kawano K, Azuma K, Uemura H, Okuno K, Matsumoto K, Yanagimoto H, Yamanaka R, Oka M, Todo S, Sasada T, Itoh K.
- Journal Title
  
  Cancer Biol Ther.
  
  Volume: 10(12) Pages: 1266-1279
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] Phase-I clinical study of a personalized peptide vaccination available for six different HLA (HLA-A2, -A3, -A11, -A24, -A31, and -A33)-positive patients with advanced cancer2011
- Author(s)
  Yamada A, Noguchi M, Komatsu N, 他7名
- Journal Title
  
  Exp Ther Med
  
  Volume: 2 Pages: 109-117
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292
[Journal Article] Overcoming the hurdles of randomised clinical trials of therapeutic cancer vaccines.2010
- Author(s)
  Sasada T, Komatsu N, Suekane S, Yamada A, Noguchi M, Itoh K.
- Journal Title
  
  Eur J Cancer. 46(9)
  
  Pages: 1514-9
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metastatic colorectal carcinoma patients2010
- Author(s)
  Hattori T, Mine T, Komatu N, Yamada A, Itoh K, Shiozaki H, Okuno K.
- Journal Title
  
  Cancer Immunol.Immunother. (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] A phase I study of personalized peptide vaccination for advanced urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and cisplatin.2010
- Author(s)
  Matsumoto K, Noguchi M, Satoh T, Tabata KI, Fujita T, Iwamura M, Yamada A, Komatsu N, Baba S, Itoh K.
- Journal Title
  
  BJU Int. 16
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] Prophylactic effect of peptide vaccination against hepatocellular carcinoma associated with hepatitis Cvirus.2010
- Author(s)
  Komatsu N, Yutani S, Yamada A, Shichijo S, Yoshida K, Itou M, Kuromatsu R, Ide T, Tanaka M, Sata M, Itoh K.
- Journal Title
  
  Exp Ther Med. 1(4)
  
  Pages: 619-626
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] A randomized phase II trial of personalized peptide vaccine plus low dose estramustine (EMP) versus standard dose EMP in patients with hormone refractory prostate cancer.2010
- Author(s)
  Noguchi M, Kakuma T, Uemura H, Nasu Y, Kumon H, Moriya F, Suekane S, Komatsu N, Yamada A, Itoh K.
- Journal Title
  
  Cancer Immunol.Immunother. 59(7)
  
  Pages: 1001-9
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] Evaluation of a new oil adjuvant for use in peptide-based cancer vaccination.2010
- Author(s)
  Iseki K, Matsunaga H, Komatsu N, Suekane S, Noguchi M, Itoh K, Yamada A.
- Journal Title
  
  Cancer Sci.
  
  Volume: 101(10) Pages: 2110-2114
- NAID
  10027832060
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] A phase I study of personalized peptide vaccination for advanced urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and cisplatin.2010
- Author(s)
  Matsumoto K, Noguchi M, Satoh T, Tabata KI, Fujita T, Iwamura M, Yamada A, Komatsu N, Baba S, Itoh K.
- Journal Title
  
  BJU Int.
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] A randomized phase II trial of personalized peptide vaccine pluslow dose estramustine(EMP)versus standard dose EMP in patients with hormone refractory prostate cancer2010
- Author(s)
  Noguchi M, Kakuma T, Uemura H, Nasu Y, Kumon H, Moriya F, Suekane S, Komatsu N, Yamada A, Itoh K.
- Journal Title
  
  Cancer Immunol.Immunother. (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] A phase II study of personalized peptide vaccination combined with gemcitabine for non-resectable pancreatic cancer patients.2010
- Author(s)
  Yanagimoto H, Shiomi H, Satoi S, Mine T, Toyokawa H, Yamamoto T, Tani T, Yamada A, Kwon A, Komatsu N, Itoh K, Noguchi M.
- Journal Title
  
  Oncol Rep.
  
  Volume: 24(3) Pages: 795-801
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] Overcoming the hurdles of randomised clinical trials of therapeutic cancer vaccines.2010
- Author(s)
  Sasada T, Komatsu N, Suekane S, Yamada A, Noguchi M, Itoh K.
- Journal Title
  
  Eur J Cancer.
  
  Volume: 46(9) Pages: 1514-1519
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] A phase II study of personalized peptide vaccination combined with gemcitabine for non-resectable pancreatic cancer patients.2010
- Author(s)
  Yanagimoto H, Shiomi H, Satoi S, Mine T, Toyokawa H, Yamamoto T, Tani T, Yamada A, Kwon A, Komatsu N, Itoh K, Noguchi M.
- Journal Title
  
  Oncol Rep. 24(3)
  
  Pages: 795-801
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] A randomized phase II trial of personalized peptide vaccine plus low dose estramustine (EMP) versus standard dose EMP in patients with hormone refractory prostate cancer.2010
- Author(s)
  Noguchi M, Kakuma T, Uemura H, Nasu Y, Kumon H, Moriya F, Suekane S, Komatsu N, Yamada A, Itoh K.
- Journal Title
  
  Cancer Immunol.Immunother.
  
  Volume: 59(7) Pages: 1001-1009
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] Evaluation of a new oil adjuvant for use in peptide-based cancer vaccination.2010
- Author(s)
  Iseki K, Matsunaga H, Komatsu N, Suekane S, Noguchi M, Itoh K, Yamada A.
- Journal Title
  
  Cancer Sci. 101(10)
  
  Pages: 2110-4
- NAID
  10027832060
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] Recent advances in cancer vaccines : an overview.2009
- Author(s)
  Itoh K, Yamada A, Mine T, Noguchi M.
- Journal Title
  
  Jpn J Clin Oncol. 39(2)
  
  Pages: 73-80
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different HLA-class I-A alleles.2009
- Author(s)
  Yutani S, Komatsu N, Shichijo S, Yoshida K, Takedatsu H, Itou M, Kuromatu R, Ide T, Tanaka M, Sata M, Yamada A, Itoh K.
- Journal Title
  
  Cancer Science 100(10)
  
  Pages: 1935-42
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metastatic colorectal carcinoma patients.2009
- Author(s)
  Hattori T, Mine T, Komatu N, Yamada A, Itoh K, Shiozaki H, Okuno K.
- Journal Title
  
  Cancer Immunol.Immunother. 58(11)
  
  Pages: 1843-52
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] A peptide derived from hepatitis C virus (HCV) core protein including cellular responses in patients infected with HCV with various HLA class IA alleles.2009
- Author(s)
  Niu Y, Komatsu N, Komohara Y, Matsueda S, Yutani S, Is hihara Y, Itou M, Yamada A, Itoh K, Shichijo S.
- Journal Title
  
  J. Med. Virol. (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different HLA-class I-A alleles2009
- Author(s)
  Yutani S, Komatsu N, Shichijo S, Yoshida K, Takedatsu H, Itou M, Kuromatu R, Ide T, Tanaka M, Sata M, Yamada A, Itoh K.
- Journal Title
  
  Cancer Science 100(10)
  
  Pages: 1935-1942
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.2009
- Author(s)
  Azuma K, Sasada T, Kawahara A, Takamori S, Hattori S, Ikeda J, Itoh K, Yamada A, Kage M, Kuwano M, Aizawa H.
- Journal Title
  
  Lung Cancer. 64(3)
  
  Pages: 326-33
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] A peptide derived from hepatitis C virus(HCV)core protein inducing cellular responses in patients infected with HCV with various HLA class IA allele2009
- Author(s)
  Niu Y, Komatsu N, Komohara Y, Matsueda S, Yutani S, Ishihara Y, Itou M, Yamada A, Itoh K, Shichijo S.
- Journal Title
  
  J.Med.Virol. 81(7)
  
  Pages: 1232-1240
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel2009
- Author(s)
  Azuma K, Sasada T, Kawahara A, Takamori S, Hattori S, Ikeda J, Itoh K, Yamada A, Kage M, Kuwano M, Aizawa H.
- Journal Title
  
  Lung Cancer. 64(3)
  
  Pages: 326-333
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] A peptide derived from hepatitis C virus (HCV) core protein inducing cellular responses in patients infected with HCV with various HLA class IA allele.2009
- Author(s)
  Niu Y, Komatsu N, Komohara Y, Matsueda S, Yutani S, Ishihara Y, Itou M, Yamada A, Itoh K, Shichijo S.
- Journal Title
  
  J.Med.Virol. 81(7)
  
  Pages: 1232-40
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] Identification of EphB6 variant-derived epitope peptides recognized by cytotoxic T-lymphocytes from HLA-A24^+ malignant glioma patients.2008
- Author(s)
  Jin M, Komohara Y, Shichijo S, Harada M, Yamanaka R, Miyamoto S, Nikawa J, Itoh K, Yamada A.
- Journal Title
  
  Oncol. Report 19(5)
  
  Pages: 1277-1283
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] Dexamethasone did not suppress immune boosting by personalized peptide vaccination for advanced prostate cancer patients.2008
- Author(s)
  Naito M, Itoh K, Komatsu N, Yamashita Y, Shirakusa T, Yamada A, Moriya F, Ayatuka H, Mohamed ER, Matsuoka K, Noguchi M.
- Journal Title
  
  Prostate 68
  
  Pages: 1753-1762
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] EphB6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in HLA-A2+ glioma patients.2008
- Author(s)
  Jin M, Komohara Y, Shichijo S, Nikawa J, Yamanaka R, Itoh K, Yamada A.
- Journal Title
  
  Cancer Scl. 99(8)
  
  Pages: 1656-1662
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] EphB6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in HLA-A2+ glioma patients.2008
- Author(s)
  Jin M, Komohara Y, Shichijo S, Nikawa J, Yamanaka R, Itoh K, Yamada A.
- Journal Title
  
  Cancer Sci. 99(8)
  
  Pages: 1656-62
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] Dexamethasone did not suppress immune boosting by personalized peptide vaccination for advanced prostate cancer patients.2008
- Author(s)
  Naito M, Itoh K, Komatsu N, Yamashita Y, Shirakusa T, Yamada A, Moriya F, Ayatuka H, Mohamed ES, Matsuoka K, Noguchi M
- Journal Title
  
  Prostate 68 (peer review)
  
  Pages: 1753-1762
- Data Source
  KAKENHI-PROJECT-19591877
[Journal Article] Identification of EphB6 variant-derived epitope peptides recognized by cytotoxic T-lymphocytes from HLA-A24^+ malignant glioma patients.2008
- Author(s)
  Jin M, Komohara Y, Shichijo S, Harada M, Yamanaka R, Miyamoto S, Nikawa J, Itoh K, Yamada A.
- Journal Title
  
  Oncol.Report 19(5)
  
  Pages: 1277-83
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] Arandomized clinical trial of an ethanol extract of Ganoderma lucidum in men with lower urinary tract symptoms.2008
- Author(s)
  Noguchi M, Kakuma T, Tomiyasu K, Yamada A, Itoh K, Konishi F, Kumamoto S, Shimizu K, Kondo R, Matsuoka K.
- Journal Title
  
  Asian J.Androl. 10(5)
  
  Pages: 777-85
- Data Source
  KAKENHI-PROJECT-20590799
[Journal Article] Identification of a peptide derived from HCV inducing cellular responses with various HLA class I -A alleles.2007
- Author(s)
  Shichijo S, Komohara Y, Matsueda S, Yutani S, Komatsu N, Sata M, Yamada A, Itoh K
- Journal Title
  
  The 66th Annual Meeting of the Japanese Cancer Association.(Yokohama) 10/3-5
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Identification of Lek-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles.2007
- Author(s)
  Naito M, Komohara Y, Ishihara Y, Noguchi M, Yamashita Y, Shirakusa T, Yamada A, Itoh K, Harada M
- Journal Title
  
  British J Cancer 97
  
  Pages: 1648-1654
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Serum levels of IgG to the peptide of HCVlb core at positions 35-44 correlated with persistent infection, while levels of IgG to the peptide of NS5A at positions 2132-2140 correlated with better prognosis in HCV-infected patients.2007
- Author(s)
  Takao Y, Yamada A, Yutani S, Ono T, Nagao Y, Ando E, Ide T, Itoh K, Sata M
- Journal Title
  
  Med Microbiol Immunol. 196
  
  Pages: 157-164
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] A new epitope peptide derived from hepatitis C virus lb possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLAA11, -A3l and A33.2007
- Author(s)
  Matsueda S, Yamada Y, et. al.
- Journal Title
  
  Cancer Immuaol Immunother. 56(9)
  
  Pages: 1359-66
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18590756
[Journal Article] Identification of new immunogenic peptides in conserved regions of hepatitis C virus(HCV) lb that can induce both cellular and humoral immunity in HCV1b+ HLA-A24^+ patients.2007
- Author(s)
  Takao Y, Yamada A, et. al.
- Journal Title
  
  Hepatol Res. 37(3)
  
  Pages: 186-95
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18590756
[Journal Article] Combination therapy of personalized peptide vaccination with low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients : an analysis of prognostic factors in the treatment.2007
- Author(s)
  Noguchi M, Mine T, Yamada A, Obata Y, Yoshida K, Mizoguchi J, Harada M, Suekane S, Itoh K, Matuoka K
- Journal Title
  
  Oncol Res 16
  
  Pages: 341-349
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Identification of Lck-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles.2007
- Author(s)
  Naito N, Yoshihiro K, Ishihara Y, Noguchi M, Yamashita Y, Shirakusa T, Yamada A, Itoh K, Harada M
- Journal Title
  
  Br J Cancer 97 (peer review)
  
  Pages: 1648-1654
- Data Source
  KAKENHI-PROJECT-19591877
[Journal Article] Personalized peptide vaccination for cancer patient.2007
- Author(s)
  Itoh K, Noguti M, Yamanaka R, Yamada A, Shichijo S
- Journal Title
  
  The 27th General Assembly of the Japan Medical Congress.(Osaka) 4/6-8
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Phase 1 clinical study of a personalized peptide vaccination for patientsinfected with hepatitis C virus(HCV) lb who failed to respond to interferon-based therapy.2007
- Author(s)
  Yutani S, Yamada A, et. al.
- Journal Title
  
  Vaccine 25(42)
  
  Pages: 7429-35
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18590756
[Journal Article] Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus(HCV) lb who failed to respond to interferon-based therapy.2007
- Author(s)
  Yutani S, Yamada A, Yoshida K, Takao Y, Tamura M, Komatsu N, Ide T, Tanaka M, Sata M, Itoh K
- Journal Title
  
  Vaccine 25
  
  Pages: 7429-35
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] A new epitope peptide derived from hepatitis C virus lb possessing the capacity to induce cytotoxic T-lymphocytes in HCVlb-infected patients with HLA-A11, -A31 and -A33.2007
- Author(s)
  Matsueda S, Yamada A, Takao Y, Tamura M, Komatsu N, Yutani S, Ide T, Sata M, Itoh K
- Journal Title
  
  Cancer Immunol Immunother. 56
  
  Pages: 1359-66
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Identification of hepatitis C virus(HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.2006
- Author(s)
  Wang Y, Takao Y, Harada M, Komatsu N, Ono T, Sata M, Itoh, K, Yamada A
- Journal Title
  
  Cell Immunol 241
  
  Pages: 38-46
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Nonmutated Self-Antigen-Derived Cancer Vaccine Peptides Elicit an lgE-Independent but Mast Cell-Dependent Immediate-Type Skin Reaction without Systemic Anaphylaxis.2006
- Author(s)
  Yamada A
- Journal Title
  
  J Immunol 176・2
  
  Pages: 857-63
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Nonmutated self-antigen-derived cancer vaccine peptides elicit an IgE-independent but mast cell-dependent immediate-type skin reaction without systemic anaphylaxis.2006
- Author(s)
  Yamada A, Yano H, Takao Y, Ono T, Matsumoto T, Itoh K
- Journal Title
  
  J Immunol 176
  
  Pages: 857-863
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Nonmutated Self-Antigen-Derived Cancer Vaccine Peptides Elicit an IgE-Independent but Mast Cell-Dependent Immediate-Type Skin Reaction without Systemic Anaphylaxis.2006
- Author(s)
  Yamada A, Yano H, Takao Y, Ono T, Matsumoto T, Itho K.
- Journal Title
  
  J Immunol. 176(2)
  
  Pages: 857-863
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] New epitope peptides derived from Hepatitis C virus(HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2 HCV-infected patients.2006
- Author(s)
  Wang Y, Yamada A, et. al.
- Journal Title
  
  dicrobiol. Immunol. 50(11)
  
  Pages: 857-65
- NAID
  10018398215
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18590756
[Journal Article] Anti-tumor effects of systemic and local immunization with a cytotoxic T lymphocyte-directed peptide in combination with a local injection of OK-432.2006
- Author(s)
  Ono T, Harada M, Yamada A, Tanaka M, Takao Y, Tanaka Y, Mine T, Sakamoto K, Nakashima T, Itoh K.
- Journal Title
  
  Clin Cancer Res. 12(4)
  
  Pages: 1325-1332
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Identification of hepatitis C virus(HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24^+ and HCV2a-infected patients.2006
- Author(s)
  Wang Y, Yamada A, et. al.
- Journal Title
  
  Dell. Immuani. 241(1)
  
  Pages: 38-46
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18590756
[Journal Article] New epitope peptides derived from hepatitis C virus(HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patients.2006
- Author(s)
  Wang Y, Takao Y, Harada M, Yutani S, Ide T, Sata M, Itoh K, Yamada A
- Journal Title
  
  Microbiol Immunol 50
  
  Pages: 857-865
- NAID
  10018398215
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Nonmutated self-antigen-derived cancer vaccine peptides elicit an IgE-independent but mast cell-dependent immediate-type skin reaction without systemic anaphylaxis.2006
- Author(s)
  Yamada A., Itoh K., et al.
- Journal Title
  
  J Immunol. 176
  
  Pages: 857-863
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Prostate-specific antigen-reactive cytotoxic T lymphocyte precursors in colon cancer patients.2006
- Author(s)
  Wang Y, Harada M, Yano H, Ogasawara S, Tanaka M, Yamada A, Itoh K.
- Journal Title
  
  Oncol Rep. 15(2)
  
  Pages: 317-321
- NAID
  120005587482
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Nonmutated self-antigen-derived cancer vaccine peptides elicit an IgE-independent but mast cell-dependent immediate-type skin reaction without systemic anaphylaxis.2006
- Author(s)
  Yamada A
- Journal Title
  
  J Immunol. 176・2
  
  Pages: 857-863
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] High expression of APOBEC3G in patients infected with hepatitis C virus.2006
- Author(s)
  Komohara Y, Yamada A, et. al.
- Journal Title
  
  J. Mol. Histol. 37(8-9)
  
  Pages: 327-32
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18590756
[Journal Article] Antitumor effects of systemic and local immunization with a CTL-directed peptide in combination with a local injection of OK-432.2006
- Author(s)
  Ono T, Harada M, Yamada A, Tanaka M, Takao Y, Tanaka Y, Mine T, Sakamoto K, Nakashima T, Itoh K
- Journal Title
  
  Clin Cancer Res 12
  
  Pages: 1325-1332
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Identification of hepatitis C virus 1b-derived peptides recognized by both cellular and humoral immune systems in HCV1b^+ HLA-A24^+ patients.2005
- Author(s)
  Tamura M, Yamada A, Takao Y, Matsueda S, Komatsu N, Yutani S, Ibe T, Sata M, Itoh K.
- Journal Title
  
  Hepatol Res. 32(4)
  
  Pages: 227-234
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Immunological evaluation of personalized peptide vaccination for patients with pancreatic cancer.2005
- Author(s)
  Yamamoto K, Mine T, Katagiri K, Suzuki N, Kawaoka T, Ueno T, Matsueda S, Yamada A, Itoh K, Yamana H, Oka M.
- Journal Title
  
  Oncol Rep. 13(5)
  
  Pages: 875-883
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Immunological evaluation of individualized peptide vaccination with a low dose of estramustine for HLA-A24(+)HRPC patients.2005
- Author(s)
  Noguchi M, Itoh K, Yao A, Mine T, Yamada A, Obata Y, Furuta M, Harada M, Suekane S, Matsuoka K.
- Journal Title
  
  Prostate. 63(1)
  
  Pages: 1-12
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Immunological evaluation of vaccination of peptides derived from epithelial cancer-related antigens in two patients with hematological malignancy.2005
- Author(s)
  Takedatsu H, Yoshimoto K, Okamura T, Yakushij K, Imamura R, Hashiguchi M, Seki R, Obata Y, Harada M, Yamada A, Yamana H, Sata M, Itoh K.
- Journal Title
  
  Int J Oncol. 26(6)
  
  Pages: 1605-1612
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant glioma.2005
- Author(s)
  Yajima N, Yamanaka R, Mine T, Tsuchiya N, Honma J, Sano M, Kuramoto T, Obata Y, Komatsu N, Arima Y, Yamada A, Shigemori M, Itoh K, Tanaka R.
- Journal Title
  
  Clin Cancer Res. 11(16)
  
  Pages: 5900-5911
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Prostatic acid phosphatase as a target molecule in specific immunotherapy for patients with non-prostate adenocarcinoma.2005
- Author(s)
  Wang Y, Harada M, Yano H, Ogasawara S, Takedatsu H, Arima Y, Matsueda S, Yamada A, Itoh K.
- Journal Title
  
  J Immunother. 28(6)
  
  Pages: 535-541
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Efficiency of personalized peptide vaccination for hormone-refractory prostate cancer patients.(Japanese)2005
- Author(s)
  Noguchi M, Suekane S, Tomiyasu K, Matsuoka K, Obata Y, Yoshida K, Mizoguchi J, Mine T, Yamada A, Itoh K.
- Journal Title
  
  Nishinihon J Uro. 67(6)
  
  Pages: 376-384
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] A phase I trial of CTL-precursor-oriented peptide vaccine for colorectal carcinoma patients.2004
- Author(s)
  Sato Y, Maeda Y, Sasatomi T, Takahashi M, Une Y, Kondo M, Shinohara T, Hida N, Katagiri K, Sato K, Yamada A, Yamana H, Itoh K, Todo S.
- Journal Title
  
  Br J Cancer. 90(7)
  
  Pages: 1334-1342
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Natural antibodies reactive to self peptides which had been identified as cytotoxic T-lymphocyte(CTL)-directed tumor antigens.2004
- Author(s)
  Fukuda K, Takao Y, Miyazaki Y, Itoh K, Yamada A.
- Journal Title
  
  Immunobiology. 209(3)
  
  Pages: 245-253
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Immunological evaluation of pre-designated vaccination of the peptides frequently vaccinated to cancer patients in an individualized peptide regimen.2004
- Author(s)
  Mochizuki K, Sato Y, Tsuda N, Shomura H, Sakamoto M, Matsuura K, Ushijima K, Maeda Y, Katagiri K, Yamada A, Todo S, Kamura T, Itoh K.
- Journal Title
  
  Int J Oncol. 25(1)
  
  Pages: 121-131
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Vaccination with pre-designated or evidence-based peptides for patients with recurrent gynecologic cancers.2004
- Author(s)
  Tsuda N, Mochizuki K, Harada M, Sukehiro A, Kawano K, Yamada A, Ushijima K, Sugiyama T, Nishida T, Yamana H, Itoh K, Kamura T.
- Journal Title
  
  J Immunother. 27(1)
  
  Pages: 60-67
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Phase I trial of patient-oriented vaccination in HLA-A2 positive patients with metastatic hormone refractory prostate cancer.2004
- Author(s)
  Noguchi M, Itoh K, Suekane S, Yao A, Suetsugu N, Katagiri K, Yamada A, Yamana H, Noda S.
- Journal Title
  
  Cancer Sci. 95(1)
  
  Pages: 77-84
- NAID
  10013721469
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] T cell receptor Vβ gene usage by T cells reactive with the tumor rejection antigen SART-1 in oral squamous cell carcinoma.2004
- Author(s)
  Kumamaru W, Nakamura S, Kadena T, Yamada A, Kawamura E, Sasaki M, Ohyama Y, Toyoshima T, Hayashida J, Itoh K, Shirasuna K.
- Journal Title
  
  Int J Cancer. 108(5)
  
  Pages: 686-695
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing peptide-specific cellular responses.2004
- Author(s)
  Mine T, Sato Y, Noguchi M, Sasatomi T, Gouhara R, Tsuda N, Tanaka S, Shomura H, Katagiri K, Rikimaru T, Shichijo S, Kamura T, Hashimoto T, Shirouze K, Yamada A, Todo S, Itoh K, Yamana H.
- Journal Title
  
  Clin Cancer Res. 10(3)
  
  Pages: 929-937
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Analysis of cellular localization of SART3 tumor antigen by newly established monoclonal antibody : Heterotopic expression of SART3 tumor antigen on the surface of B-lineage leukemic cells.2004
- Author(s)
  Koga M, Komatsu N, Shichijo S, Itoh K, Yamada A.
- Journal Title
  
  Oncol Rep. 11(4)
  
  Pages: 785-789
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Immunological monitoring during combination of patient-oriented peptide vaccination and estramustin phosphate I patients with metastatic hormone refractory prostate cancer.2004
- Author(s)
  Noguchi M, Itoh K, Suekane S, Morinaga A, Sukehiro A, Suetsugu N, Katagiri K, Yamada A, Noda S.
- Journal Title
  
  Prostate. 60(1)
  
  Pages: 32-45
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Antibody reactive to a hepatitis C virus(HCV)-derived peptide capable of inducing HLA-A2 restricted cytotoxic T lymphocytes is detectable in the majority of HCV-infected individuals without HLA-A2 restriction.2004
- Author(s)
  Takao Y, Yamada A, Yutani S, Sata M, Itoh K.
- Journal Title
  
  Microbiol Immunol. 48(7)
  
  Pages: 507-517
- NAID
  10013297451
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Gena and peptide analyses of newly defined lung cancer rejection antigens recognized by HLA-A2402-restricted tumor-specific cytotoxic T lymphocytes.2003
- Author(s)
  Yamada A
- Journal Title
  
  Cancer Res. 63-11
  
  Pages: 282-35
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Induction of cellular and humoral immune responses to tumor cells and peptides in HLA-A24 positive hormone-refractory prostate cancer patients by peptide vaccination.2003
- Author(s)
  Noguchi M, Kobayashi K, Suetsugu N, Tomiyasu K, Suekane S, Yamada A, Itoh K, Noda S.
- Journal Title
  
  Prostate. 57(1)
  
  Pages: 80-92
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Identification of cytotoxic T lymphocyte-directed epitope encoded by an intron of putative tumor suppresser gene Testin of the common fragile site 7G region at 7q31.2 : Peptide vaccine candidate for HLA-B52^+ and -62^+ cancer patients.2003
- Author(s)
  Ohkouchi S, Kawamoto N, Sakanashi F, Shichijo S, Saijo Y, Nukiwa T, Itoh K, Yamada A.
- Journal Title
  
  Eur J Immunol. 33(11)
  
  Pages: 2964-2973
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide.2003
- Author(s)
  Sato Y, Shomura H, Maeda Y, Mine T, Une Y, Akasaka Y, Kondo M, Takahashi S, Shinohara T, Katagiri K, Sato M, Okada S, Matsui K, Yamada A, Yamana H, Itoh K, Todo S.
- Journal Title
  
  Cancer Sci. 94(9)
  
  Pages: 802-808
- NAID
  50000305125
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Depolymerization of actin filament by cytochalasin E induces interleukin-8 production and up-regulates CD54 in the Hela epithelial cell line.2003
- Author(s)
  Ikewaki N, Yamada A, Inoko H.
- Journal Title
  
  Microbiol Immunol. 47(10)
  
  Pages: 775-783
- NAID
  10011758021
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] IgG reactive to CTL-directed epitope peptides is either lacking or unbalanced in atopic dermatitis patients.2003
- Author(s)
  Kawamoto N, Ohkouchi S, Maeda T, Tanaka S, Hashimoto T, Saijo S, Saijo Y, Shichijo S, Itoh K, Yamada A.
- Journal Title
  
  Tissue Antigens. 61(5)
  
  Pages: 352-361
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Immunological evaluation of CTL precursor-oriented vaccines for advanced lung cancer patients.2003
- Author(s)
  Mine T, Gouhara R, Hida N, Imai N, Azuma K, Rikimaru T, Katagiri K, Nishikori M, Sukehiro A, Nakagawa M, Yamada A, Aizawa H, Shirouzu K, Itoh K, Yamana H.
- Journal Title
  
  Cancer Sci. 94(6)
  
  Pages: 548-556
- NAID
  50000864627
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Peptide vaccination for patients with melanoma and other types of cancers based on pre-existing peptide-specific cytotoxic T lymphocyte precursors in the periphery.2003
- Author(s)
  Tanaka S, Harada M, Mine T, Noguchi M, Gohara R, Azuma K, Tamura M, Yamada A, Morinaga A, Nishikori M, Katagiri K, Itoh K, Yamana H, Hashimoto T.
- Journal Title
  
  J Immunother. 26(4)
  
  Pages: 357-366
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Identification of ribosomal proteins S2 and L10a as tumor-rejection antigens recognized by HLA-A26-restricted CTL.2003
- Author(s)
  Koga M, Shichijo S, Yamada A, Ashihara J, Sawamizu H, Kusakawa J, Itoh K.
- Journal Title
  
  Tissue Antigens. 61(2)
  
  Pages: 136-145
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Journal Article] Gene and peptide analyses of newly defined lung cancer rejection antigens recognized by HLA-A2402-restricted tumor-specific cytotoxic T lymphocytes.2003
- Author(s)
  Yamada A, Kawano K, Koga M, Takamori S, Nakagawa M, Itoh K.
- Journal Title
  
  Cancer Res. 63(11)
  
  Pages: 2829-2835
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Patent] コアジュバント組成物およびこれを含むワクチン組成物2016
- Inventor(s)
  山田亮、和氣加容子
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Rights Type
  特許
- Filing Date
  2016-08-09
- Data Source
  KAKENHI-PROJECT-26430176
[Patent] ペプチドカクテルワクチン2013
- Inventor(s)
  伊東恭悟、野口正典、山田亮、他5名
- Industrial Property Rights Holder
  伊東恭悟、野口正典、山田亮、他5名
- Industrial Property Rights Type
  特許
- Filing Date
  2013-05-09
- Overseas
- Data Source
  KAKENHI-PROJECT-23501292
[Patent] ペプチドカクテルワクチン2013
- Inventor(s)
  伊東恭悟、野口正典、笹田哲朗、由谷茂、山田亮、小松誠和、松枝智子、七條茂樹
- Industrial Property Rights Holder
  久留米大学
- Industrial Property Rights Type
  特許
- Filing Date
  2013-05-09
- Overseas
- Data Source
  KAKENHI-PROJECT-23501292
[Patent] がんの検査用試薬及び検査方法2012
- Inventor(s)
  伊東恭悟、笹田哲朗、松枝智子、小松誠和、野口正典、山田亮、七條茂樹
- Industrial Property Rights Holder
  久留米大学
- Industrial Property Rights Type
  特許
- Filing Date
  2012-06-22
- Overseas
- Data Source
  KAKENHI-PROJECT-23501292
[Patent] がんの検査用試薬及び検査方法2012
- Inventor(s)
  伊東恭悟、野口正典、山田亮、他4名
- Industrial Property Rights Holder
  伊東恭悟、野口正典、山田亮、他4名
- Industrial Property Rights Type
  特許
- Filing Date
  2012-06-22
- Overseas
- Data Source
  KAKENHI-PROJECT-23501292
[Patent] 特異免疫機能診断キット2011
- Inventor(s)
  伊東恭悟、笹田哲郎、山田　亮、他4名
- Industrial Property Rights Holder
  伊東恭悟、笹田哲郎、山田　亮、他4名
- Filing Date
  2011
- Overseas
- Data Source
  KAKENHI-PROJECT-23501292
[Patent] C型肝炎ウイルス由来ペプチド2009
- Inventor(s)
  山田亮、伊東恭悟、佐田通夫、由谷茂
- Industrial Property Rights Holder
  (株)グリーンペプタイド
- Acquisition Date
  2009-07-17
- Data Source
  KAKENHI-PROJECT-20590799
[Patent] C型肝炎ウイルスによる肝癌の発症および再発予防ワクチン2009
- Inventor(s)
  伊東恭悟,佐田通夫,山田亮,由谷茂
- Industrial Property Rights Holder
  久留米大学
- Filing Date
  2009-10-27
- Data Source
  KAKENHI-PROJECT-20590799
[Patent] C型肝炎ウイルス由来ペプチド2009
- Inventor(s)
  山田亮、伊東恭悟、佐田通夫、由谷茂
- Industrial Property Rights Holder
  (株)グリーンペプタイド
- Acquisition Date
  2009-07-17
- Data Source
  KAKENHI-PROJECT-20590799
[Patent] C型肝炎ウイルスによる肝癌の発症および再発予防ワクチン2008
- Inventor(s)
  伊東恭悟,佐田通夫,山田亮,由谷茂
- Industrial Property Rights Holder
  久留米大学
- Industrial Property Number
  2008-276163
- Filing Date
  2008-10-27
- Data Source
  KAKENHI-PROJECT-20590799
[Patent] C型肝炎ウイルス由来ペプチド2008
- Inventor(s)
  山田亮、伊東恭悟、佐田通夫、由谷茂
- Industrial Property Rights Holder
  (株)グリーンペプタイド
- Filing Date
  2008-09-16
- Data Source
  KAKENHI-PROJECT-20590799
[Patent] C型肝炎ウイルス由来ペプチド2008
- Inventor(s)
  山田亮、伊東恭悟、佐田通夫、由谷茂
- Industrial Property Rights Holder
  (株)グリーンペプタイド
- Filing Date
  2008-12-15
- Data Source
  KAKENHI-PROJECT-20590799
[Patent] C型肝炎ウイルスによる肝癌の発症および再発予防ワクチン2008
- Inventor(s)
  伊東恭悟, 佐田通夫, 山田亮, 由谷茂
- Industrial Property Rights Holder
  久留米大学
- Industrial Property Number
  2008-276163
- Filing Date
  2008-10-27
- Data Source
  KAKENHI-PROJECT-20590799
[Patent] C型肝炎ウイルス2a由来HLA-A2拘束性抗原ペプチド2007
- Inventor(s)
  山田亮, 伊東恭悟, 佐田通夫,
- Industrial Property Rights Holder
  学校法人久留米大学
- Filing Date
  2007-01-23
- Data Source
  KAKENHI-PROJECT-18590756
[Patent] C型肝炎ウイルス由来ペプチド2007
- Inventor(s)
  伊東恭悟, 佐田通夫, 山田亮, 由谷茂
- Industrial Property Rights Holder
  学校法人久留米大学
- Filing Date
  2007-01-23
- Data Source
  KAKENHI-PROJECT-18590756
[Patent] C型肝炎ウィルス由来ペプチド2006
- Inventor(s)
  伊東恭悟, 佐田通夫, 山田亮, 由谷茂
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2006-220542
- Filing Date
  2006-08-11
- Data Source
  KAKENHI-PROJECT-18590756
[Patent] C型肝炎ウイルス由来ペプチド2006
- Inventor(s)
  伊東恭悟, 佐田通夫, 山田亮, 由谷茂
- Industrial Property Rights Holder
  学校法人久留米大学
- Filing Date
  2006-08-29
- Data Source
  KAKENHI-PROJECT-18590756
[Patent] C型肝炎ウイルス2a由来HLA-A2拘束性抗原ペプチド2006
- Inventor(s)
  山田亮, 伊東恭悟, 佐田通夫
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2006-013980
- Filing Date
  2006-01-23
- Data Source
  KAKENHI-PROJECT-15590834
[Patent] 生理活性ペプチドのエマルション製剤の調整方法、および当該製剤を調整するためのキット2006
- Inventor(s)
  山田亮, 道渕浩世, 小幡武照, 井上允孝, 宮坂忠与
- Industrial Property Rights Holder
  (株)グリーンペプタイド, 東洋紡績(株)
- Industrial Property Number
  2006-014057
- Filing Date
  2006-01-23
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Patent] C型肝炎ウイルス由来ペプチド2006
- Inventor(s)
  伊東恭悟, 佐田通夫, 山田亮, 由谷茂
- Industrial Property Rights Holder
  学校法人久留米大学
- Filing Date
  2006-08-10
- Data Source
  KAKENHI-PROJECT-18590756
[Patent] C型肝炎ウイルス由来ペプチド2006
- Inventor(s)
  山田亮, 伊東恭悟, 佐田通夫, 由谷茂
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2006-014000
- Filing Date
  2006-01-23
- Data Source
  KAKENHI-PROJECT-15590834
[Patent] C型肝炎ウィルス由来2006
- Inventor(s)
  山田亮, 伊東恭悟, 佐田通夫, 由谷茂
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2006-014000
- Filing Date
  2006-01-23
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Patent] C型肝炎ウィルス2a由来HLA-A2拘束性抗原ペプチド2006
- Inventor(s)
  山田亮, 伊東恭悟, 佐田通夫
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2006-013980
- Filing Date
  2006-01-23
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Patent] C型肝炎ウィルス由来ペプチド2005
- Inventor(s)
  伊東恭悟, 山田亮, 佐田通夫, 由谷茂
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2005-359511
- Filing Date
  2005-12-20
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Patent] C型肝炎ウイルス由来ペプチド2005
- Inventor(s)
  伊東恭悟, 山田亮, 佐田通夫, 由谷茂
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2005-359511
- Filing Date
  2005-12-20
- Data Source
  KAKENHI-PROJECT-15590834
[Patent] C型肝炎ウィルス感染に関連する肝疾患の予後の予測2005
- Inventor(s)
  伊東恭悟, 佐田通夫, 由谷茂, 小松誠和, 山田亮
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2005-121293
- Filing Date
  2005-04-19
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Patent] C型肝炎ウイルス感染に関連する肝疾患の予後の予測2005
- Inventor(s)
  伊東恭悟, 佐田通夫, 由谷茂, 小松誠和, 山田亮
- Industrial Property Rights Holder
  学校法人久留米大学
- Filing Date
  2005-04-19
- Data Source
  KAKENHI-PROJECT-15590834
[Patent] C型肝炎ウィルス由来ペプチドとインターフェロンとの併用療法2005
- Inventor(s)
  伊東恭悟, 佐田通夫, 由谷茂, 山田亮
- Industrial Property Rights Holder
  (株)グリーンペプタイド
- Industrial Property Number
  2005-020982
- Filing Date
  2005-01-28
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Patent] C型肝炎ウィルス由来A3スーパーファミリー拘束性抗原ペプチド2005
- Inventor(s)
  伊東恭悟, 佐田通夫, 由谷茂, 山田亮
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2005-310203
- Filing Date
  2005-10-25
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Patent] C型肝炎ウイルス由来A3スーパーファミリー拘束性抗原ペプチド2005
- Inventor(s)
  伊東恭悟, 佐田通夫, 由谷茂, 山田亮
- Industrial Property Rights Holder
  学校法人久留米大学
- Filing Date
  2005-10-25
- Data Source
  KAKENHI-PROJECT-15590834
[Patent] C型肝炎ウィルス由来ペプチド2003
- Inventor(s)
  伊東恭悟, 山田亮, 佐田通夫
- Industrial Property Rights Holder
  (株)グリーンペプタイド
- Industrial Property Number
  2003-330258
- Filing Date
  2003
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15590834
[Presentation] Locoregional T cell subset analysis in Esophageal Squamous Cell Carcinoma2018
- Author(s)
  Tomoya Sudo, Kawahara Akihiko, Haruhiro Hino, Yuya Tanaka, Hideaki Kaku, Hiroyuki Nakane, Saisho Kouhei, Taizan Minami, Matono Satoru, Mori Naoki, Tanaka Toshiaki, Mimori Koshi, Yamada Akira, Akagi Yoshito
- Organizer
  日本癌治療学会
- Data Source
  KAKENHI-PROJECT-16K07130
[Presentation] 末梢血セルフリーDNA integrityはペプチドワクチン療法において有用なバイオマーカーとなりうる：非小細胞肺がんでの解析2018
- Author(s)
  和氣加容子、山田亮
- Organizer
  第22回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-17K07229
[Presentation] Plasma cell-free DNA integrity analyses for ovarian and non-small cell lung cancer patients with peptide vaccination2018
- Author(s)
  和氣加容子、山田亮
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K07229
[Presentation] PDL1 expression and tumor infiltrating lymphocyte subset analysis in primary esophageal cancer tissue2017
- Author(s)
  Tomoya Sudo, Mizoguchi Atsushi, Kawahara Akihiko, Haruhiro Hino, Saisho Kouhei, Nagasu Sachiko, Taizan Minami, Matono Satoru, Mori Naoki, Tanaka Toshiaki, Mimori Koshi, Yamada Akira, Akagi Yoshito
- Organizer
  日本癌学会
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K07130
[Presentation] Trial of Analysis The Expression of PDL1 Expression and The Subset of Tumor Infiltrating Lymphocyte in Esophageal Squamous Cell Carcinoma2017
- Author(s)
  Tomoya Sudo, Mizoguchi Atsushi, Kawahara Akihiko, Haruhiro Hino, Saisho Kouhei, Nagasu Sachiko, Taizan Minami, Matono Satoru, Mori Naoki, Nanaka Toshiaki, Mimori Koshi, Yamada Akira, Akagi Yoshito
- Organizer
  日本癌治療学会
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K07130
[Presentation] Randomized phase II trials of personalized peptide vaccination in advanced cancers2016
- Author(s)
  ITO Kyogo、YUTANI Shigeru、SHICHIJO Sigeki、NOGUCHI Masanori、SASADA Tetsuro、YAMADA Akira、UEMURA Hirotsugu
- Organizer
  第20回日本がん免疫学会総会
- Place of Presentation
  大阪国際交流センター（大阪市）
- Year and Date
  2016-07-27
- Data Source
  KAKENHI-PROJECT-26430176
[Presentation] 乳癌におけるペプチドワクチン療法の臨床開発-The Development of Therapeutic Peptide Vaccines for Metastatic Recurrent Breast Cancer-2016
- Author(s)
  唐　宇飛、岩熊伸高、岡部実奈、朔　周子、赤木由人、山田　亮、七條茂樹、伊東恭悟
- Organizer
  第29回日本バイオセラピィ学会学術集会総会
- Place of Presentation
  久留米
- Year and Date
  2016-12-01
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] HMGB1 阻害剤はコアアジュバントとしてペプチドワクチンで誘導される抗腫瘍免疫を増強する2016
- Author(s)
  和氣加容子、山田亮
- Organizer
  第75回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜（横浜市）
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-26430176
[Presentation] 食道癌組織におけるT細胞レセプターレパートリーの包括的解析2016
- Author(s)
  主藤朝也、溝口充志、河原明彦、西田良介、門屋一貴、最所公平、長主祥子、森直樹、的野吾、田中寿明、山田亮、三森功士、赤木由人
- Organizer
  第75回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜（横浜市）
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-26430176
[Presentation] 乳癌におけるペプチドワクチン療法後の抗前立腺関連抗原(prostate-related antigen)血清抗体価の臨床的意義2016
- Author(s)
  唐　宇飛、岡部実奈、岩熊伸高、三島麻衣、山田　亮、七條茂樹、伊東恭悟、笹田哲朗、赤木由人
- Organizer
  第116回日本外科学会定期学術集会
- Place of Presentation
  大阪
- Year and Date
  2016-04-14
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] 血清抗前立腺関連抗原 (prostate-related antigen) 抗体価の乳癌ペプチドワクチン療法における臨床的意義に関する検討2016
- Author(s)
  唐宇飛、岩熊伸高、岡部実奈、朔周子、赤司桃子、赤木由人、山田亮、七條茂樹、伊東恭悟
- Organizer
  第75回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜（横浜市）
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-26430176
[Presentation] The clinical development of therapeutic peptide vaccines for breast cancer treatmemt2016
- Author(s)
  Uhi Toh,,Nobutaka Iwakuma,Mina Okabe,Shuko Saku,Momoko Akashi,Shigeki Shichijo,Kyogo Itoh,Akira Yamada,Yoshito Akagi
- Organizer
  The 14th Asian Breast Diseases Association Meeting & Symposium
- Place of Presentation
  Fukuoka
- Year and Date
  2016-09-02
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] 治療抵抗性トリプルネガティブ乳癌に対して19種混合ペプチドワクチン（KRM-19)が著効した1例2016
- Author(s)
  朔　周子、唐　宇飛、岩熊伸高、岡部実奈、山田　亮、七條茂樹、伊東恭悟、赤木由人
- Organizer
  第29回日本バイオセラピィ学会学術集会総会
- Place of Presentation
  久留米
- Year and Date
  2016-12-01
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] High mobility group box 1 (HMGB1) 阻害剤はコアアジュバントとしてペプチドワクチンで誘導される抗腫瘍免疫を増強する2016
- Author(s)
  和氣加容子、山田亮
- Organizer
  第20回日本がん免疫学会総会
- Place of Presentation
  大阪国際交流センター（大阪市）
- Year and Date
  2016-07-27
- Data Source
  KAKENHI-PROJECT-26430176
[Presentation] トリプルネガティブ乳癌に対する混合ペプチドワクチン（KRM-19)の早期第2相臨床試験2016
- Author(s)
  朔　周子、唐　宇飛、岩熊伸高、三島麻衣、岡部実奈、君付優子、赤木由人、七條茂樹、山田　亮、伊東恭悟
- Organizer
  第24回日本乳癌学会学術集会
- Place of Presentation
  東京
- Year and Date
  2016-06-16
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] 血清抗前立腺関連抗原(prostate-related antigen)抗体価の乳癌ペプチドワクチン療法における臨床的意義に関する検討2016
- Author(s)
  唐　宇飛、岩熊伸高、岡部実奈、朔　周子、赤司桃子、赤木由人、山田　亮、七條茂樹、伊東恭悟
- Organizer
  第75回日本癌学会学術集会
- Place of Presentation
  横浜
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] 転移再発トリプルネガティブ乳癌に対するテーラメイド癌ペプチドワクチン療法第Ⅱ相試験2015
- Author(s)
  高橋龍司、唐　宇飛、岩熊伸高、中川志乃、松枝智子、山田　亮、伊東恭悟、赤木由人、笹田哲朗
- Organizer
  第115回日本外科学会定期学術集会
- Place of Presentation
  名古屋
- Year and Date
  2015-04-16
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] CTL AND IGG RESPONSE TO TUMOR-ASSOCIATED ANTIGENS AS PREDICTIVE FACTORS OF THEREPEUTIC PEPTIDE VACCINATION FOR PATIENTS WITH METASTATIC RECURRENT BREAST CANCER2015
- Author(s)
  Uhi Toh,Mina Okabe,Nobutaka Iwakuma,Mai Mishima,Shigeki Shichijo,Akira Yamada,Kyogo Itoh,Yoshito Akagi
- Organizer
  Advanced Breast Cancer/Third International Consensus Conference
- Place of Presentation
  Portugal,リスボン
- Year and Date
  2015-11-05
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] Feasibility study of personalized peptide vaccination for cervical cancer patients who have received prior cisplatin-based chemotherapy2015
- Author(s)
  Kayoko Waki, Kouichiro Kawano, Kyogo Itoh, Akira Yamada
- Organizer
  ICCIM 2015 (International Conference of Cancer Immunortherapy and Macrophages 2015)
- Place of Presentation
  東京大学伊藤謝恩ホール（東京都）
- Year and Date
  2015-07-09
- Data Source
  KAKENHI-PROJECT-26430176
[Presentation] テーラーメイドペプチドワクチン（PPV）療法と漢方の併用療法における免疫賦活能の検討2015
- Author(s)
  古賀紀子、守屋普久子、松枝智子、和氣加容子、山田　亮、伊東恭悟、野口正典
- Organizer
  第28回日本バイオセラピィ学会学術集会総会
- Place of Presentation
  川越東武ホテル（埼玉）
- Year and Date
  2015-12-03
- Data Source
  KAKENHI-PROJECT-26430176
[Presentation] 去勢抵抗性前立腺癌に対する低用量シクロホスファミド併用ペプチドワクチン療法の第2相無作為比較試験2015
- Author(s)
  野口正典、守屋普久子、古賀紀子、松枝智子、笹田哲朗、山田　亮、角間辰之、伊東恭悟
- Organizer
  第28回日本バイオセラピィ学会学術集会総会
- Place of Presentation
  川越東武ホテル（埼玉）
- Year and Date
  2015-12-03
- Data Source
  KAKENHI-PROJECT-26430176
[Presentation] Serum IgG response against prostate-related antigen revealed by personalized peptide vaccination in patients with metastatic recurrent breast cancer Local immunologic environment related with tumor infiltrating lymphocytes (TIL) and PD-1/PD-L1 expression in early stage breast cancer2015
- Author(s)
  Toh U, Okabe M, Iwakuma N, Mishima M, Shichijo S, Yamada A, Noguchi M, Itoh K, Akagi Y.
- Organizer
  SanAntonio Breast Cancer Symposium 2015
- Place of Presentation
  USA, SanAntonio
- Year and Date
  2015-12-08
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] １９種ペプチドワクチン（KRM-19)によるトリプルネガティブ乳癌の早期第2相試験2015
- Author(s)
  唐　宇飛、岡部実奈、岩熊伸高、三島麻衣、山田　亮、七條茂樹、伊東恭悟、赤木由人
- Organizer
  第５３回日本癌治療学会学術集会
- Place of Presentation
  京都
- Year and Date
  2015-10-29
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] Feasibility studies of personalized peptide vaccination for advanced gynecologic cancer patients2015
- Author(s)
  Kayoko Waki, Kouichiro Kawano, Testuro Sasada, Kimio Ushijima, Kyogo Itoh, Toshiharu Kamura, Akira Yamada
- Organizer
  第74回日本癌学会学術総会
- Place of Presentation
  名古屋国際会議場（名古屋市）
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-26430176
[Presentation] Randomized phase II study of personalized peptide vaccination with cyclophosphamide pretreatment in refractory advanced biliary tract cancer patients.2014
- Author(s)
  Sasada T, Yutani S, Matsueda S, Shirahama T, Yamada A, Itoh K.
- Organizer
  2014 ASCO Annual Meeting.
- Place of Presentation
  Chicago, USA
- Year and Date
  2014-06-01
- Data Source
  KAKENHI-PROJECT-26430176
[Presentation] 既二次治療進行非小細胞癌に対するテーラーメイドペプチドワクチン療法の臨床第Ⅱ相試験2014
- Author(s)
  坂本信二郎、山田哲平、寺崎泰宏、吉山康一、松枝智子、小松誠和、和氣加容子、山田亮、菅原俊一、笹田哲朗、高森信三、伊東恭悟
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜（横浜市）
- Year and Date
  2014-09-25
- Data Source
  KAKENHI-PROJECT-26430176
[Presentation] ペプチドワクチンの最近の進歩2014
- Author(s)
  伊東恭悟、野口正典、山田亮、七條茂樹、笹田哲朗、松枝智子、小松誠和
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜（横浜市）
- Year and Date
  2014-09-25
- Data Source
  KAKENHI-PROJECT-26430176
[Presentation] Lck由来新規Tヘルパーエピトープの同定2014
- Author(s)
  松枝智子、七條茂樹、山田亮、笹田哲朗、伊東恭悟
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜（横浜市）
- Year and Date
  2014-09-25
- Data Source
  KAKENHI-PROJECT-26430176
[Presentation] 既二次治療進行非小細胞癌に対するテーラーメイドペプチドワクチン療法の臨床第Ⅱ相試験2014
- Author(s)
  坂本信二郎、山田哲平、寺崎泰宏、吉山康一、松枝智子、小松誠和、和氣加容子、山田亮、河原明彦、鹿毛政義、菅原俊一、木下裕一、笹田哲朗、高森信三、伊東恭悟
- Organizer
  第18回日本がん免疫学会総会
- Place of Presentation
  ひめぎんホール（愛媛県松山市）
- Year and Date
  2014-07-31
- Data Source
  KAKENHI-PROJECT-26430176
[Presentation] PD-1 expression on peripheral blood T-cell subsets correlates with prognosis in non-small cell lung cancer2014
- Author(s)
  和氣加容子、山田哲平、吉山康一、坂本信二郎、松枝智子、小松誠和、菅原俊一、高森信三、伊東恭悟、山田亮
- Organizer
  第18回日本がん免疫学会総会
- Place of Presentation
  ひめぎんホール（愛媛県松山市）
- Year and Date
  2014-07-31
- Data Source
  KAKENHI-PROJECT-26430176
[Presentation] Relationship between　haptoglobin　promoter　polymorphism　and　peptide　vaccine-induced　immune　responses　in NSCLC patients2014
- Author(s)
  和氣加容子、山田哲平、寺崎泰宏、坂本信二郎、菅原俊一、高森信三、伊東恭悟、山田亮
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜（横浜市）
- Year and Date
  2014-09-25
- Data Source
  KAKENHI-PROJECT-26430176
[Presentation] 去勢抵抗性前立腺がんを対象としたマルチペプチド混合カクテルワクチンKRM20の第Ⅰ相試験2014
- Author(s)
  山田亮、野口正典、新井学、松本和将、内藤誠二、守屋普久子、末金茂高、小松誠和、松枝智子、笹田哲朗、伊東恭悟
- Organizer
  第18回日本がん免疫学会総会
- Place of Presentation
  ひめぎんホール（愛媛県松山市）
- Year and Date
  2014-07-31
- Data Source
  KAKENHI-PROJECT-26430176
[Presentation] Phase I trial of a novel cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer.2013
- Author(s)
  Noguchi M, Arai G, Matsumoto K, Naito S, Moriya F, Suekane S, Sasada T, Yamada A, Itoh K.
- Organizer
  The Congress of the Soci Internationale d’Urologie　(SIU)
- Place of Presentation
  Vancouver, Canada
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] 去勢抵抗性前立腺がん患者を対象とした20 ペプチド混合ワクチンの第1相臨床試験2013
- Author(s)
  山田亮
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  横浜市
- Year and Date
  2013-10-04
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] Phase I trial of a novel cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer.2013
- Author(s)
  Akira Yamada, Masanori Noguchi, Kyogo Itoh
- Organizer
  11th CIMT Annual Meeting(CIMT)
- Place of Presentation
  マインツ・ドイツ
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] Phase II randomized study of personalized peptide vaccine for patients with early stages of castration-resistant prostate cancer2013
- Author(s)
  山田亮
- Organizer
  第17回日本がん免疫学会総会
- Place of Presentation
  宇部市
- Year and Date
  2013-07-03
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] Phase I trial of a novel cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer2013
- Author(s)
  Akira Yamada
- Organizer
  11th CIMT Annual Meeting(CIMT)
- Place of Presentation
  マインツ・ドイツ
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] テーラーメイドがんペプチドワクチンの現状2012
- Author(s)
  山田亮
- Organizer
  第16回日本がん免疫学会総会
- Place of Presentation
  札幌市
- Year and Date
  2012-07-28
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] 化学療法抵抗性進行膵がん患者に対するセカンドラインとしてのテーラーメイドペプチドワクチン療法2012
- Author(s)
  山田亮
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌市
- Year and Date
  2012-09-21
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] C型肝炎肝硬変からの発がん予防および肝がん術後再発予防ワクチンの開発2011
- Author(s)
  山田亮
- Organizer
  第15回日本がん免疫学会総会
- Place of Presentation
  大阪市
- Year and Date
  2011-06-30
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] 分子標的治療時代における進行性腎癌に対するがんペプチドワクチン療法の可能性2011
- Author(s)
  末金茂高、守屋普久子、松岡啓、笹田哲朗、伊東恭悟、野口正典、山田亮
- Organizer
  第49回日本癌治療学会学術集会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] Identification of Predictive Biomarkers in Cancer Patients Receiving Personalized Peptide Vaccination.2011
- Author(s)
  Sasada T, Matsueda S, Shichijo S, Ioji T, Komatsu N, Noguchi M, Yamada A, Itoh K.
- Organizer
  26th Annual Meeting of Society for Immunotherapy of Cancer.
- Place of Presentation
  Bethesda, MD, USA.
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] 標準治療抵抗性尿路上皮がんに対するテーラーメイドペプチドワクチン療法第II相試験2011
- Author(s)
  末金茂高、野口正典、守屋普久子、松岡啓、小松誠和、笹田哲朗、山田亮、伊東恭悟
- Organizer
  第３２回癌免疫外科研究会
- Place of Presentation
  和歌山
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] 去勢抵抗性前立腺がんに対するペプチドワクチン療法の予後規定バイオマーカー：中間解析2011
- Author(s)
  野口正典、守屋普久子、末金茂高、笹田哲朗、山田亮、伊東恭悟
- Organizer
  第49回日本癌治療学会学術集会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] 前立腺癌に対するテーラーメイドがんペプチドワクチン臨床試験2011
- Author(s)
  山田　亮、野口正典、伊東恭悟
- Organizer
  第70回日本癌学会総会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] テーラーメイドがんペプチドワクチン療法の予後予測に有用なバイオマーカー2011
- Author(s)
  笹田哲朗、松枝智子、七條茂樹、小松誠和、野口正典、山田亮、伊東恭悟
- Organizer
  第70回日本癌学会総会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] Ｃ型肝炎肝硬変からの発がん予防および肝がん術後再発予防ワクチンの開発2011
- Author(s)
  山田　亮、由谷　茂、伊東恭悟
- Organizer
  第15回日本がん免疫学会総会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] Predictive Biomarker in Cancer Patients Receiving Personalized Peptide Vaccination.2011
- Author(s)
  Sasada T, Matsueda S, Shichijo S, Komatsu N, Noguchi M, Yamada A, Itoh K.
- Organizer
  第70回日本癌学会総会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] 前立腺癌に対するテーラーメイドがんペプチドワクチン臨床試験2011
- Author(s)
  山田亮
- Organizer
  第70回日本癌学会総会
- Place of Presentation
  名古屋市
- Year and Date
  2011-10-05
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] がんワクチン療法の現状と展望2011
- Author(s)
  山田亮
- Organizer
  第29回日本口腔腫瘍学会総会・学術大会
- Place of Presentation
  崇城大学市民ホール(熊本県)(招待講演)
- Year and Date
  2011-01-27
- Data Source
  KAKENHI-PROJECT-20590799
[Presentation] 再発卵巣：卵管がんにおけるテーラーメイドがんペプチドワクチン療法第II相臨床試験；予後予測バイオマーカーの探索2011
- Author(s)
  河野光一郎、津田尚武、福井章正、牛嶋公生、笹田哲朗、山田亮、伊東恭悟、嘉村敏治
- Organizer
  第49回日本癌治療学会学術集会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] がんワクチン療法の現状と展望2011
- Author(s)
  山田亮
- Organizer
  第29回日本言腔腫瘍学会総会・学術大会
- Place of Presentation
  崇城大学市民ホール(熊本県)(招待講演)
- Year and Date
  2011-01-27
- Data Source
  KAKENHI-PROJECT-20590799
[Presentation] テーラーメイドペプチドワクチン療法の現状と今後2011
- Author(s)
  伊東恭悟、野口正典、寺崎瑞彦、笹田哲朗、山田亮
- Organizer
  第49回日本癌治療学会学術集会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] 標準治療抵抗性肺癌に対するテーラーメイドペプチドワクチン療法第II相臨床試験2011
- Author(s)
  寺崎泰宏、吉山康一、高森信三、峯孝志、笹田哲朗、山田亮、伊東恭悟、白水和雄
- Organizer
  第49回日本癌治療学会学術集会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] Identification of Predictive Biomarkers in Cancer Patients Receiving Personalized Peptide Vaccination.2011
- Author(s)
  Sasada T, Matsueda S, Shichijo S, Ioji T, Komatsu N, Noguchi M, Yamada A, Itoh K.
- Organizer
  第15回日本がん免疫学会総会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] 進行胆道がんに対するテーラーメイドペプチドワクチン療法2011
- Author(s)
  吉富宗宏、由谷茂、峯孝志、山田亮、笹田哲朗、松枝智子、七條茂樹、伊東恭悟、木下壽文、青柳成明
- Organizer
  第111回日本外科学会定期学術集会
- Place of Presentation
  紙上開催
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] 標準治療抵抗性肺がんに対するテーラーメイドペプチドワクチン療法第2相臨床試験2010
- Author(s)
  吉山康一、高森信三、寺崎泰宏、山田亮、由谷茂、小松誠和、七條茂樹、伊東恭悟、野口正典、白水和雄
- Organizer
  第14回日本がん免疫学会総会
- Place of Presentation
  KKRホテル熊本(熊本県)
- Year and Date
  2010-07-22
- Data Source
  KAKENHI-PROJECT-20590799
[Presentation] 婦人科癌におけるテーラーメイドがんペプチドワクチン療法の第II相臨床試験(中間報告)2010
- Author(s)
  河野光一郎、津田尚武、牛嶋公生、小松誠和、山田亮、伊東恭悟、嘉村敏治
- Organizer
  第14回日本がん免疫学会総会
- Place of Presentation
  KKRホテル熊本(熊本県)
- Year and Date
  2010-07-22
- Data Source
  KAKENHI-PROJECT-20590799
[Presentation] テーラーメイドペプチドワクチンの新たな展開2010
- Author(s)
  山田亮、伊東恭悟
- Organizer
  第14回日本がん免疫学会総会
- Place of Presentation
  KKRホテル熊本(熊本県)
- Year and Date
  2010-07-22
- Data Source
  KAKENHI-PROJECT-20590799
[Presentation] ドセタキセル抵抗性再燃前立腺がんに対するテーラーメイドペプチドワクチン第II相臨床試験2010
- Author(s)
  守屋普久子、末金茂高、山田亮、小松誠和、笹田哲朗、七條茂樹、伊東恭悟、野口正典
- Organizer
  第14回日本がん免疫学会総会
- Place of Presentation
  KKRホテル熊本(熊本県)
- Year and Date
  2010-07-22
- Data Source
  KAKENHI-PROJECT-20590799
[Presentation] Development of peptide vaccine therapy for cancer2010
- Author(s)
  山田亮、野口正典、伊東恭悟
- Organizer
  第69回日本癌学会学術総会
- Place of Presentation
  RIHGA Royal Hotel Osaka(大阪府)
- Year and Date
  2010-07-22
- Data Source
  KAKENHI-PROJECT-20590799
[Presentation] 胆道がんに対するテーラーメイドペプチドワクチン治療2010
- Author(s)
  吉富宗宏、由谷茂、吉山康一、峯孝志、山田亮、小松誠和、七條茂樹、伊東恭悟、木下壽文、野口正典
- Organizer
  第14回日本がん免疫学会総会
- Place of Presentation
  KKRホテル熊本(熊本県)
- Year and Date
  2010-07-22
- Data Source
  KAKENHI-PROJECT-20590799
[Presentation] Immunological and clinical effects of personalized peptide vaccine for advanced cancer2009
- Author(s)
  山田亮、野口正典、藤堂省、柳本泰明、山中龍也、岡正朗、松本和将、峯孝志、松岡啓、伊東恭悟
- Organizer
  第12回基盤的癌免疫研究会総会
- Place of Presentation
  大宮ソニックシティ(埼玉県)
- Year and Date
  2009-07-03
- Data Source
  KAKENHI-PROJECT-20590799
[Presentation] ホルモン不応性再燃前立腺がんに対するテーラーメイドがんペプチドワクチン療法のランダム化比較試験2009
- Author(s)
  山田亮、野口正典、小松誠和、伊東恭悟
- Organizer
  第68回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜(神奈川県)
- Year and Date
  2009-10-01
- Data Source
  KAKENHI-PROJECT-20590799
[Presentation] MVAC耐性進行・再発膀胱癌に対するテーラーメイド癌ペプチドワクチン療法の検討2009
- Author(s)
  松本和将、佐藤威文、岩村正嗣、小松誠和、峯孝志、山田亮、伊東恭悟、馬場志郎
- Organizer
  第13回日本がん免疫学会総会
- Place of Presentation
  北九州(福岡県)
- Year and Date
  2009-06-24
- Data Source
  KAKENHI-PROJECT-20590799
[Presentation] テーラーメイドペプチドワクチン療法の現状と展望2009
- Author(s)
  山田亮
- Organizer
  第13回日本がん免疫学会総会
- Place of Presentation
  北九州(福岡県)
- Year and Date
  2009-06-24
- Data Source
  KAKENHI-PROJECT-20590799
[Presentation] 2年以上の長期テーラーメイド型ペプチドワクチン療法を行った進行再燃前立腺癌患者の免疫学的検討2009
- Author(s)
  野口正典、末金茂高、守屋普久子、山田亮、伊東恭悟、松岡啓
- Organizer
  第12回基盤的癌免疫研究会総会
- Place of Presentation
  大宮ソニックシティ(埼玉県)
- Year and Date
  2009-07-03
- Data Source
  KAKENHI-PROJECT-20590799
[Presentation] テーラーメイドがんペプチドワクチン:実用化の展望2009
- Author(s)
  山田亮、野口正典、由谷茂、伊東恭悟
- Organizer
  第46回日本臨床分子医学会学術集会
- Place of Presentation
  東京国際フォーラム(東京都)
- Year and Date
  2009-04-12
- Data Source
  KAKENHI-PROJECT-20590799
[Presentation] 膵臓癌におけるテーラーメイドペプチドワクチンとゲムシタビンの併用療法第II相臨床試験2009
- Author(s)
  小松誠和、柳本泰明、山田亮、七條茂樹、伊東恭悟
- Organizer
  第68回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜(神奈川県)
- Year and Date
  2009-10-02
- Data Source
  KAKENHI-PROJECT-20590799
[Presentation] がんワクチン開発の現状と展望2009
- Author(s)
  山田亮
- Organizer
  第16回薬と医療シンポジウム
- Place of Presentation
  兵庫医療大学オクタホール(兵庫県)
- Year and Date
  2009-08-29
- Data Source
  KAKENHI-PROJECT-20590799
[Presentation] Immunological and clinical effects of personalized peptide vaccine for HLA-A2 positive patients with advanced cancer.2008
- Author(s)
  Noguchi M, Todo S, Yanagimoto H, Yamanaka R, Kamura T, Matsumoto T, Mine T, Yamada A,Itoh K
- Organizer
  ASCO 2008 (American Society of Clinical Oncology) Annual Meeting
- Place of Presentation
  シカゴ
- Year and Date
  2008-06-01
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] HLA-A26前列腺癌患者およびHCV感染者に対するワクチン候補ペプチドの解析2008
- Author(s)
  牛亜梅, 寺崎康展, 小松誠和, 野口正典, 七條茂樹, 山田亮, 伊東恭悟
- Organizer
  第67回日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2008-10-28
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] C型肝炎ウイルス感染者に対する治療を目的としたペプチドワクチンの臨床試験2008
- Author(s)
  山田亮、由谷茂、佐田通夫、伊東恭悟
- Organizer
  第67回日本癌学会学術総会
- Place of Presentation
  名古屋国際会議場(愛知県)
- Year and Date
  2008-10-30
- Data Source
  KAKENHI-PROJECT-20590799
[Presentation] Determination of vaccine candidates for HLA-A26 positive patients with prostate cancer or HCV-related diseases.2008
- Author(s)
  牛亜梅, 寺崎康展, 小松誠和, 野口正典, 七條茂樹, 山田亮, 伊東恭悟
- Organizer
  第67回日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2008-10-30
- Data Source
  KAKENHI-PROJECT-20590799
[Presentation] 2年以上の長期テーラーメイド型ペプチドワクチン療法を行った進行再燃前立腺癌患者の免疫学的検討2008
- Author(s)
  野口正典, 末金茂高, 守屋普久子, 山田亮, 伊東恭悟, 松岡啓
- Organizer
  第12回基盤的癌免疫研究会総会
- Place of Presentation
  埼玉
- Year and Date
  2008-07-02
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] A phase I trial of personalized peptide vaccination for cytokine-refractory metastatic renal cell carcinoma patients.2008
- Author(s)
  Suekane S, Noguchi M, Komohara Y, Nishitani M, Niroh M, Honma S, Yamada A, Kanayama H, Itoh K, Matuoka K
- Organizer
  第23回 EAU (European Association of Urology) Annual Meeting
- Place of Presentation
  ミラノ
- Year and Date
  2008-03-26
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] HLA-A26前立腺癌患者およびHCV感染者に対するワクチン候補ペプチドの解析2008
- Author(s)
  牛亜梅、寺崎康展、小松誠和、野口正典、七條茂樹、山田亮、伊東恭悟
- Organizer
  第67回日本癌学会学術総会
- Place of Presentation
  名古屋国際会議場(愛知県)
- Year and Date
  2008-10-29
- Data Source
  KAKENHI-PROJECT-20590799
[Presentation] テーラーメイド癌ペプチドワクチン臨床試験の生存解析:475症例でのアップデート2008
- Author(s)
  峯孝志, 野口正典, 藤堂省, 柳本泰明, 植村天受, 山中龍也, 嘉村敏治, 岡正朗, 奥野清隆, 松本和将, 山田亮, 伊東恭悟
- Organizer
  第67回日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2008-10-29
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] Immunological and clinical effects of personalized peptide vaccine for advanced cancer2008
- Author(s)
  Noguchi M, Todo S, Yanagimoto H, Yamanaka R, Oka M, Matsumoto T, Mine T, Yamada A,Matsuoka K, Itoh K
- Organizer
  UICC 2008 (International Union Against Cancer) World Cancer Congress
- Place of Presentation
  ジュネーブ
- Year and Date
  2008-08-31
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] Clinical trial of therapeutic peptide vaccine of Hepatitis C virus infection.2008
- Author(s)
  山田亮, 由谷茂, 佐田通夫, 伊東恭悟
- Organizer
  第67回日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2008-10-30
- Data Source
  KAKENHI-PROJECT-20590799
[Presentation] テーラーメイド癌ペプチドワクチン臨床試験の生存解析:475症例でのアップデート2008
- Author(s)
  峯孝志、野口正典、藤堂省、柳本泰明、植村天受、山中龍也、嘉村敏治、岡正朗、奥野清隆、松本和将、山田亮、伊東恭悟
- Organizer
  第67回日本癌学会学術総会
- Place of Presentation
  名古屋国際会議場(愛知県)
- Year and Date
  2008-10-30
- Data Source
  KAKENHI-PROJECT-20590799
[Presentation] 再燃前立腺癌に対するペプチドワクチン・低用量エストラムスチン併用療法と常用量エストラムスチン単独療法とのランダム化臨床比較試験2008
- Author(s)
  野口正典, 末金茂高, 守屋普久子, 松岡啓, 植村天受, 那須保友, 公文裕巳, 山田亮, 伊東恭悟
- Organizer
  第45回日本癌治療学会総会
- Place of Presentation
  名古屋
- Year and Date
  2008-10-30
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] Immunological and clinical effects of personalized peptide vaccine for HLA-A2 positive patients with hormone refractory prostate cancer2008
- Author(s)
  Noguchi M, Itoh K, Yamada A, Moriya F, Suekane S, Matsuoka K
- Organizer
  25Th JAPAN-KOREA UROLOGICAL CONGRESS
- Place of Presentation
  岡山
- Year and Date
  2008-09-26
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] Personalized peptide vaccination for cancer patient.2007
- Author(s)
  Itoh K, Noguti M, Yamanaka R, Yamada A, Shichijo S
- Organizer
  The 27th General Assembly of the Japan Medical Congress.
- Place of Presentation
  Osaka
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Presentation] Identification of a peptide derived from HCV inducing cellular responses with various HLA class I -A alleles.2007
- Author(s)
  Shichijo S, Komohara Y, Matsueda S, Yutani S, Komatsu N, Sata M, Yamada A, Itoh K
- Organizer
  The 66th Annual Meeting of the Japanese Cancer Association.
- Place of Presentation
  Yokohama
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Presentation] テーラーメイドがんペプチドワクチン進行がんに対する新規免疫療法
- Author(s)
  笹田哲朗、野口正典、山田亮、小松誠和、松枝智子、伊東恭悟
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌市
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] Randomized phase II study of personalized peptide vaccination in patients with advanced bladder cancer progressing after chemotherapy.
- Author(s)
  Noguchi M, Moriya F, Suekane S, Matsueda S, Komatsu N, Sasada T, Yamada A, Itoh K.
- Organizer
  12th CIMT (The Association for Cancer Immunotherapy) Annual Meeting.
- Place of Presentation
  Mainz, Germany
- Year and Date
  2014-05-06 – 2014-05-08
- Data Source
  KAKENHI-PROJECT-26430176
[Presentation] 化学療法抵抗性進行膵がん患者に対するセカンドラインとしてのテーラーメイドペプチドワクチン療法
- Author(s)
  山田亮、由谷茂、松枝智子、小松誠和、峯孝志、笹田哲朗、伊東恭悟
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌市
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer : dose-related immune boosting and suppression.
- Author(s)
  Noguchi M, Arai G, Matsumoto K, Naito S, Moriya F, Suekane S, Komatsu N, Matsueda S, Sasada T, Yamada A,Itoh K.
- Organizer
  2014 WCC
- Place of Presentation
  Melbourne, Australia
- Year and Date
  2014-12-03 – 2014-12-06
- Data Source
  KAKENHI-PROJECT-26430176
[Presentation] CTLエピトープワクチン療法
- Author(s)
  伊東恭悟、山田亮、植村天受、笹田哲朗、野口正典
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  横浜市
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] Phase II randomized study of personalized peptide vaccine for patients with early stages of castration-resistant prostate cancer.
- Author(s)
  山田亮、植村天受、伊東恭悟
- Organizer
  第17回日本がん免疫学会総会
- Place of Presentation
  宇部市
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] Randomized phase II study of personalized peptide vaccination with cyclophosphamide pretreatment in refractory advanced biliary tract cancer patients.
- Author(s)
  Yutani S, Shirahama T, Komatsu N, Matsueda S, Sasada T, Yamada A, Itoh K.
- Organizer
  12th CIMT (The Association for Cancer Immunotherapy) Annual Meeting.
- Place of Presentation
  Mainz, Germany
- Year and Date
  2014-05-06 – 2014-05-08
- Data Source
  KAKENHI-PROJECT-26430176
[Presentation] 去勢抵抗性前立腺がん患者を対象とした20ペプチド混合ワクチンの第1相臨床試験
- Author(s)
  山田亮、野口正典、笹田哲朗、小松誠和、松枝智子、伊東恭悟
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  横浜市
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] ペプチドワクチン投与非小細胞肺がん患者末梢血T細胞におけるPD-1の発現
- Author(s)
  和氣加容子、松枝智子、伊東恭悟、山田亮
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  横浜市
- Data Source
  KAKENHI-PROJECT-23501292
[Presentation] Randomized phase II study of personalized peptide vaccination in patients with advanced bladder cancer progressing after chemotherapy.
- Author(s)
  Noguchi M, Matsumoto K, Uemura H, Arai G, Eto M, Naito S, Ohyama C, Nasu Y, Tanaka M, Moriya F, Suekane S, Matsueda S, Komatsu N, Sasada T, Yamada A, Itoh K.
- Organizer
  2014 ASCO Annual Meeting.
- Place of Presentation
  Chicago, USA
- Year and Date
  2014-05-30 – 2014-06-03
- Data Source
  KAKENHI-PROJECT-26430176
[Presentation] Phase II Clinical Trial of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer.
- Author(s)
  Sasada T, Yutani S, Kibe S, Matsueda S, Komatsu K, Yamada A, Akagi Y, Itoh K.
- Organizer
  12th CIMT (The Association for Cancer Immunotherapy) Annual Meeting.
- Place of Presentation
  Mainz, Germany
- Year and Date
  2014-05-06 – 2014-05-08
- Data Source
  KAKENHI-PROJECT-26430176
[Presentation] テーラーメイドがんペプチドワクチンの現状
- Author(s)
  山田亮、伊東恭悟
- Organizer
  第16回日本がん免疫学会総会
- Place of Presentation
  札幌市
- Data Source
  KAKENHI-PROJECT-23501292

1. SHICHIJO Shigeki (30080592)

# of Collaborated Projects: 6 results

# of Collaborated Products: 15 results
2. ITOH Kyogo (50125499)

# of Collaborated Projects: 5 results

# of Collaborated Products: 27 results
3. HOSHINO Tomoaki (00261066)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
4. Waki Kayoko (40649597)

# of Collaborated Projects: 3 results

# of Collaborated Products: 4 results
5. NOGUCHI Masanori (10140691)

# of Collaborated Projects: 2 results

# of Collaborated Products: 15 results
6. NAKAMURA Seiji (60189040)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
7. YOSHIDA Hiroki (40260715)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
8. YUTANI SHIGERU (20279160)

# of Collaborated Projects: 2 results

# of Collaborated Products: 6 results
9. TOH Uhi (60268901)

# of Collaborated Projects: 2 results

# of Collaborated Products: 13 results
10. Mayumi TAMURA (00506272)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. SUETSUGU NORIE (60363355)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. YAMANA Hideaki (30140669)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. SAKAMOTO Kikuo (70279222)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
14. Sudo Tomoya (50309803)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
15. 片岡明夫 (40194758)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. 内藤雅康 (00446080)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
17. 豊嶋健史 (20546569)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
18. 河野光一郎 (10320160)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
19. 三森功士 (50322748)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
20. Mizoguchi Atsushi

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
21. HATTORI Noboru

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
22. MATSUMOTO Kazumasa

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
23. FUJII Teruhiko

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
24. KAGE Masayoshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
25. KAWAHARA Akihiro

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
26. 小松誠和

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
27. 笹田哲朗

# of Collaborated Projects: 0 results

# of Collaborated Products: 23 results
28. 松枝智子

# of Collaborated Projects: 0 results

# of Collaborated Products: 15 results
29. 関直子

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
30. 庄司広和

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

YAMADA Akira 山田 亮

Research Projects

Research Products

Co-Researchers

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Role of HMGB1 on anti-tumor immunity and its application for cancer immunotherapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of next generation transdermal vaccine for cancer treatmentPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Basic research for the development of multi-peptide cocktail vaccines for cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Fundamental study for development of a peptide vaccine against hepatitis C virusPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Basic research for the development of peptide vaccination against Hepatitis C virus infectionPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Identification of new lung cancer antigens and development of peptide vaccinePrincipal Investigator

YAMADA Akira 山田亮